10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2022

OR 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                      to                     

Commission File Number 001-33458

TERADATA CORPORATION

(Exact name of registrant as specified in its charter)

Delaware	75-3236470
(State or other jurisdiction of	(I.R.S. Employer
incorporation or organization)	Identification No.)

17095 Via Del Campo

San Diego, California 92127

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (866) 548-8348

Securities registered pursuant to Section 12(b) of the Act:

Title of each class:	Trading Symbol	Name of Each Exchange on which Registered:
Common Stock, $0.01 par value	TDC	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ý    No  ¨

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ý    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer	ý	Accelerated filer	¨
Non-accelerated filer	¨	Smaller reporting company	☐
		Emerging growth company	☐

1

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ☐  No  ý

At April 29, 2022, the registrant had approximately 104.7 million shares of common stock outstanding.

2

TABLE OF CONTENTS

PART I—FINANCIAL INFORMATION

	Description	Page
Item 1.	Financial Statements
	Condensed Consolidated Statements of Income (Unaudited) Three Months Ended March 31, 2022 and 2021	4
	Condensed Consolidated Statements of Comprehensive Income (Unaudited) Three Months Ended March 31, 2022 and 2021	5
	Condensed Consolidated Balance Sheets (Unaudited) March 31, 2022 and December 31, 2021	6
	Condensed Consolidated Statements of Cash Flows (Unaudited) Three Months Ended March 31, 2022 and 2021	7
	Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) Three Months Ended March 31, 2022 and 2021	8
	Notes to Condensed Consolidated Financial Statements (Unaudited)	9
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	18
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	27
Item 4.	Controls and Procedures	28
PART II—OTHER INFORMATION
	Description	Page
Item 1.	Legal Proceedings	28
Item 1A.	Risk Factors	28
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	28
Item 3.	Defaults Upon Senior Securities	29
Item 4.	Mine Safety Disclosures	29
Item 5.	Other Information	29
Item 6.	Exhibits	30
	Signatures	31

3

Part 1—FINANCIAL INFORMATION

A

Item 1. Financial Statements.

Teradata Corporation

Condensed Consolidated Statements of Income (Unaudited)

	Three Months Ended March 31,
In millions, except per share amounts	2022		2021
Revenue
Subscription software licenses	$	93	$	93
Services and other	293		279
Total recurring	386		372
Perpetual software licenses, hardware and other	26		23
Consulting services	84		96
Total revenue	496		491
Cost of revenue
Subscription software licenses	7		4
Services and other	98		86
Total recurring	105		90
Perpetual software licenses, hardware and other	18		11
Consulting services	72		83
Total cost of revenue	195		184
Gross profit	301		307
Operating expenses
Selling, general and administrative expenses	157		149
Research and development expenses	76		77
Total operating expenses	233		226
Income from operations	68		81
Other expense, net
Interest expense	(6)		(7)
Interest income	2		1
Other expense	(9)		(3)
Total other expense, net	(13)		(9)
Income before income taxes	55		72
Income tax expense	19		19
Net income	$	36	$	53
Net income per common share
Basic	$	0.34	$	0.49
Diluted	$	0.33	$	0.47
Weighted average common shares outstanding
Basic	105.0		108.7
Diluted	108.6		112.8

See Notes to Condensed Consolidated Financial Statements (Unaudited).

4

Teradata Corporation

Condensed Consolidated Statements of Comprehensive Income (Unaudited)

	Three Months Ended March 31,
In millions	2022		2021
Net income	$	36	$	53
Other comprehensive income (loss):
Foreign currency translation adjustments	(1)		(8)
Derivatives:
Unrealized gain on derivatives, before tax	8		4
Unrealized gain on derivatives, tax portion	(2)		(1)
Unrealized gain on derivatives, net of tax	6		3
Defined benefit plans:
Defined benefit plan adjustment, before tax	3		2
Defined benefit plan adjustment, tax portion	(1)		—
Defined benefit plan adjustment, net of tax	2		2
Other comprehensive income (loss)	7		(3)
Comprehensive income	$	43	$	50

See Notes to Condensed Consolidated Financial Statements (Unaudited).

5

Teradata Corporation

Condensed Consolidated Balance Sheets (Unaudited)

In millions, except per share amounts	March 31, 2022		December 31, 2021
Assets
Current assets
Cash and cash equivalents	$	404	$	592
Accounts receivable, net	330		336
Inventories	16		26
Other current assets	113		152
Total current assets	863		1,106
Property and equipment, net	274		288
Right of use assets - operating lease, net	22		26
Goodwill	395		396
Capitalized contract costs, net	109		111
Deferred income taxes	200		202
Other assets	32		40
Total assets	$	1,895	$	2,169
Liabilities and stockholders’ equity
Current liabilities
Current portion of long-term debt	$	75	$	88
Current portion of finance lease liability	76		77
Current portion of operating lease liability	11		12
Accounts payable	78		67
Payroll and benefits liabilities	91		148
Deferred revenue	580		552
Other current liabilities	82		89
Total current liabilities	993		1,033
Long-term debt	324		324
Finance lease liability	56		53
Operating lease liability	15		18
Pension and other postemployment plan liabilities	133		138
Long-term deferred revenue	19		27
Deferred tax liabilities	16		7
Other liabilities	102		109
Total liabilities	1,658		1,709
Commitments and contingencies (Note 8)
Stockholders’ equity
Preferred stock: par value $0.01 per share, 100.0 shares authorized, no shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively	—		—
Common stock: par value $0.01 per share, 500.0 shares authorized, 104.7 and 107.2 shares issued at March 31, 2022 and December 31, 2021, respectively	1		1
Paid-in capital	1,792		1,808
Accumulated deficit	(1,425)		(1,211)
Accumulated other comprehensive loss	(131)		(138)
Total stockholders’ equity	237		460
Total liabilities and stockholders’ equity	$	1,895	$	2,169

See Notes to Condensed Consolidated Financial Statements (Unaudited).

6

Teradata Corporation

Condensed Consolidated Statements of Cash Flows (Unaudited)

	Three Months Ended March 31,
In millions	2022		2021
Operating activities
Net income	$	36	$	53
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	40		39
Stock-based compensation expense	31		21
Deferred income taxes	8		10
Changes in assets and liabilities:
Receivables	6		(36)
Inventories	10		13
Current payables and accrued expenses	(49)		(44)
Deferred revenue	20		63
Other assets and liabilities	49		(9)
Net cash provided by operating activities	151		110
Investing activities
Expenditures for property and equipment	(1)		(4)
Additions to capitalized software	—		(1)
Net cash used in investing activities	(1)		(5)
Financing activities
Repurchases of common stock	(300)		(83)
Repayments of long-term borrowings	(13)		(6)
Payments of finance leases	(22)		(15)
Other financing activities, net	4		13
Net cash used in financing activities	(331)		(91)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(6)		(5)
(Decrease) increase in cash, cash equivalents and restricted cash	(187)		9
Cash, cash equivalents and restricted cash at beginning of period	595		533
Cash, cash equivalents and restricted cash at end of period	$	408	$	542
Supplemental cash flow disclosure:
Assets acquired under operating lease	$	1	$	2
Assets acquired under finance lease	$	24	$	45
Annual variable incentive payout settled in equity	$	—	$	17

Reconciliation of cash, cash equivalents and restricted cash to the Condensed Consolidated Balance Sheets:

	March 31, 2022		December 31, 2021
Cash and cash equivalents	$	404	$	592
Restricted cash	4		3
Total cash, cash equivalents and restricted cash	$	408	$	595

See Notes to Condensed Consolidated Financial Statements (Unaudited).

7

Teradata Corporation

Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited)

	Common Stock			Paid-in		Accumulated		Accumulated Other Comprehensive
In millions	Shares	Amount		Capital		Deficit		Loss		Total
December 31, 2021	107	$	1	$	1,808	$	(1,211)	$	(138)	$	460
Net income	—	—		—		36		—		36
Employee stock compensation, employee stock purchase programs and option exercises, net of tax	3	—		34		—		—		34
Repurchase of common stock, not yet settled	—	—		(50)		—		—		(50)
Repurchases of common stock, retired	(5)	—		—		(250)		—		(250)
Pension and postemployment benefit plans, net of tax	—	—		—		—		2		2
Unrealized gain on derivatives, net of tax	—	—		—		—		6		6
Currency translation adjustment	—	—		—		—		(1)		(1)
March 31, 2022	105	$	1	$	1,792	$	(1,425)	$	(131)	$	237

	Common Stock			Paid-in		Accumulated		Accumulated Other Comprehensive
In millions	Shares	Amount		Capital		Deficit		Loss		Total
December 31, 2020	108	$	1	$	1,656	$	(1,114)	$	(143)	$	400
Net income	—	—		—		53		—		53
Employee stock compensation, employee stock purchase programs and option exercises, net of tax	4	—		52		—		—		52
Repurchases of common stock, retired	(3)	—		—		(85)		—		(85)
Pension and postemployment benefit plans, net of tax	—	—		—		—		2		2
Unrealized gain on derivatives, net of tax	—	—		—		—		3		3
Currency translation adjustment	—	—		—		—		(8)		(8)
March 31, 2021	109	$	1	$	1,708	$	(1,146)	$	(146)	$	417

See Notes to Condensed Consolidated Financial Statements (Unaudited).

8

Notes to Condensed Consolidated Financial Statements (Unaudited)

1. Basis of Presentation

These statements have been prepared pursuant to the rules and regulations of the United States Securities and Exchange Commission ("SEC") and, in accordance with those rules and regulations, do not include all information and footnote disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP"). In the opinion of management, the condensed consolidated financial statements reflect all adjustments, consisting only of normal recurring adjustments, necessary to fairly state the results of operations, financial position and cash flows of Teradata Corporation ("Teradata" or the "Company") for the interim periods presented herein. The year-end 2021 condensed consolidated balance sheet data was derived from audited financial statements but does not include all disclosures required by GAAP. The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make use of estimates and assumptions that affect the reported amounts and disclosures. Actual results may vary from these estimates. 

These condensed consolidated interim financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in Teradata’s most recent Annual Report on Form 10-K for the fiscal year ended December 31, 2021 (the "2021 Annual Report"). The results of operations for any interim period are not necessarily indicative of the results of operations to be expected for the full year.

2. New Accounting Pronouncements

Reference Rate Reform. In March 2020, the Financial Accounting Standards Board ("FASB") issued new guidance to provide relief to companies that will be impacted by the expected change in benchmark interest rates, as participating banks will no longer be required to submit London Interbank Offered Rate ("LIBOR") quotes by the U.K. Financial Conduct Authority. The new guidance allows companies to, provided the only change to existing contracts are a change to an approved benchmark interest rate, account for modifications as a continuance of the existing contract without additional analysis. For new and existing contracts, companies may elect to apply the amendments as of March 12, 2020 through December 31, 2022. The Company is currently evaluating this new guidance to determine the impact it may have on its condensed consolidated financial statements or related disclosures.

Recently Adopted Guidance

In August 2020, the FASB issued Accounting Standard Update ("ASU") 2020-06, an update to Accounting Standard Codification ("ASC") Topic 470, Subtopic - 20, Debt - Debt with Conversion and Other Options, and ASC Topic 815, Subtopic - 4, Derivatives and Hedging - Contracts in Entity's Own Equity. ASU 2020-06 simplifies the guidance for certain financial instruments with characteristics of liability and equity, including convertible instruments and contracts on an entity’s own equity by reducing the number of accounting models for convertible instruments and amends guidance in ASC Topic 260, Earnings Per Share, relating to the computation of earnings per share for convertible instruments and contracts on an entity’s own equity. The Company adopted the provisions of ASU 2020-06 on January 1, 2022. The adoption of this standard did not have an impact on the Company's condensed consolidated financial statements.

9

3. Revenue from Contracts with Customers

Disaggregation of Revenue from Contracts with Customers

The following table presents a disaggregation of revenue:

	Three Months Ended March 31,
in millions	2022		2021
Americas
Recurring	$	246	$	218
Perpetual software licenses, hardware and other	12		7
Consulting services	32		38
Total Americas	290		263
EMEA
Recurring	89		101
Perpetual software licenses, hardware and other	11		13
Consulting services	29		33
Total EMEA	129		147
APJ
Recurring	51		53
Perpetual software licenses, hardware and other	3		3
Consulting services	23		25
Total APJ	77		81
Total Revenue	$	496	$	491

Rental revenue, which is included in recurring revenue in the above table, was as follows:

	Three Months Ended March 31,
in millions	2022		2021
Rental revenue*	$	50	$	39

*Rental revenue includes hardware maintenance.

Contract Balances

The timing of revenue recognition, billings and cash collections results in billed accounts receivable, contract assets, and customer advances and deposits (deferred revenue or contract liabilities) on the condensed consolidated balance sheet. Accounts receivable include amounts due from customers that are unconditional. Contract assets relate to the Company’s rights to consideration for goods delivered or services completed and recognized as revenue but billing and the right to receive payment is conditional upon the completion of other performance obligations. Contract assets are included in other current assets on the balance sheet and are transferred to accounts receivable when the rights become unconditional. Deferred revenue consists of advance payments and billings in excess of revenue recognized. Deferred revenue is classified as either current or noncurrent based on the timing of when the Company expects to recognize revenue. These assets and liabilities are reported on a contract-by-contract basis at the end of each reporting period.

10

The following table provides information about receivables, contract assets and deferred revenue from contracts with customers:

	As of
in millions	March 31, 2022	December 31, 2021
Accounts receivable, net	330	$	336
Contract assets	17	10
Current deferred revenue	580	552
Long-term deferred revenue	19	27

Revenue recognized during the three months ended March 31, 2022 from amounts included in deferred revenue at the beginning of the period was $135 million.

Transaction Price Allocated to Unsatisfied Obligations

The following table includes estimated revenue expected to be recognized in the future related to the Company's unsatisfied (or partially satisfied) obligations at March 31, 2022:

in millions	Total at March 31, 2022		Year 1		Year 2 and Thereafter
Remaining unsatisfied obligations	$	2,281	$	1,506	$	775

The amounts above represent the price of firm orders for which work has not been performed or goods have not been delivered and exclude unexercised contract options outside the stated contractual term that do not represent material rights to the customer. Although the Company believes that the contract value in the above table is firm, approximately $1,366 million of the amount is under contracts that are subject to customer-only general cancellation for convenience terms that the Company is contractually obligated to perform unless the customer notifies us of cancellation. The Company expects to recognize revenue of approximately $446 million in the next year from contracts that are non-cancelable. The Company believes the inclusion of this information is important to understanding the obligations that the Company is contractually required to perform and provides useful information regarding remaining obligations related to these executed contracts.

4. Contract Costs

The Company capitalizes sales commissions and other contract costs that are incremental direct costs of obtaining customer contracts if the expected amortization period of the asset is greater than one year. These costs are recorded in capitalized contract costs, net on the Company’s balance sheet. The capitalized amounts are calculated based on the annual recurring revenue and contract value for individual multi-term contracts. The judgments made in determining the amount of costs incurred include whether the commissions are in fact incremental and would not have occurred absent the customer contract. Costs to obtain a contract are amortized as selling, general and administrative expenses on a straight-line basis over the expected period of benefit, which is typically around four years. These costs are periodically reviewed for impairment. The following table identifies the activity relating to capitalized contract costs:

in millions	December 31, 2021		Capitalized		Amortization		March 31, 2022
Capitalized contract costs	$	111	$	13	$	(15)	$	109

in millions	December 31, 2020		Capitalized		Amortization		March 31, 2021
Capitalized contract costs	$	98	$	13	$	(12)	$	99

11

5. Supplemental Financial Information

	As of
In millions	March 31, 2022		December 31, 2021
Inventories
Finished goods	$	7	$	17
Service parts	9		9
Total inventories	$	16	$	26
Deferred revenue
Deferred revenue, current	$	580	$	552
Long-term deferred revenue	19		27
Total deferred revenue	$	599	$	579

6. Income Taxes

Income tax provisions for interim periods are based on estimated annual income tax rates, adjusted to reflect the effects of any significant infrequent or unusual items which are required to be discretely recognized within the current interim period. The Company expects that a majority of its foreign earnings will be repatriated back to the United States ("U.S."). As a result, the effective tax rates in the periods presented are largely based upon the forecasted pre-tax earnings mix and allocation of certain expenses in various taxing jurisdictions where the Company conducts its business.

The effective tax rate is as follows:

	Three Months Ended March 31,
In millions	2022		2021
Effective tax rate	34.5	%	26.4	%

For the three months ended March 31, 2022, the Company recorded $4 million of net discrete tax benefits, a majority of which related to the excess tax benefit derived from stock compensation vesting. In addition, the Company’s effective tax rate increased by 9% as a result of an increase in the Company’s forecasted global intangible low-taxed income ("GILTI") tax liability as described below.

For the three months ended March 31, 2021, the Company recorded $3 million of discrete tax benefit, a majority of which related to the excess tax benefit derived from stock compensation vesting.

The Company estimates its annual effective tax rate for 2022 to be approximately 37%, which takes into consideration, among other things, the forecasted earnings mix by jurisdiction and the impact of discrete tax items to be recognized in 2022. Under U.S. tax law, U.S. shareholders are subject to a tax on GILTI earned by certain foreign subsidiaries. The Company has elected to provide for the tax expense related to GILTI in the year in which the tax is incurred. Effective on January 1, 2022, the U.S. tax law changed and now requires R&D expenses to be capitalized and amortized for tax purposes under Internal Revenue Code Section 174; as a result of this law change, the Company is currently forecasting approximately $12 million of tax expense related to GILTI in our marginal effective tax rate for 2022. Should Congress enact proposed legislation to defer the implementation of R&D capitalization rules retroactively by the end of the year, the Company’s GILTI tax and overall effective tax rate for 2022 would be significantly reduced.

7. Derivative Instruments and Hedging Activities

As a portion of Teradata’s operations is conducted outside the U.S. and in currencies other than the U.S. dollar, the Company is exposed to potential gains and losses from changes in foreign currency exchange rates. In an attempt to mitigate the impact of currency fluctuations, the Company uses foreign exchange forward contracts to hedge

12

transactional exposures resulting predominantly from foreign currency denominated inter-company receivables and payables. The forward contracts are designated as fair value hedges of specified foreign currency denominated inter-company receivables and payables and generally mature in three months or less. The fair values of foreign exchange contracts are based on market spot and forward exchange rates and represent estimates of possible value that may not be realized in the future. Across its portfolio of contracts, Teradata has both long and short positions relative to the U.S. dollar. As a result, Teradata’s net involvement is less than the total contract notional amount of the Company’s foreign exchange forward contracts.

Gains and losses from foreign exchange forward contracts are fully recognized each period and reported along with the offsetting gain or loss of the related hedged item, either in cost of revenues, operating expenses or in other income (expense), depending on the nature of the related hedged item.

In June 2018, Teradata executed a five-year interest rate swap with a $500 million initial notional amount to hedge the floating interest rate of its term loan, as more fully described in Note 10. The Company uses interest rate swaps to manage interest rate risks on future interest payments caused by interest rate changes on its variable rate term loan. The notional amount of the hedge steps down according to the amortization schedule of the term loan. The notional amount of the hedge was $400 million as of March 31, 2022.

The Company performed an initial effectiveness assessment on the interest rate swap, and the hedge was determined to be effective. The hedge is being evaluated qualitatively on a quarterly basis for effectiveness. Changes in fair value are recorded in Accumulated Other Comprehensive Loss and periodic settlements of the swap will be recorded in interest expense along with the interest on amounts outstanding under the term loan.

The following table identifies the contract notional amount of the Company’s derivative financial instruments:

	As of
In millions	March 31, 2022		December 31, 2021
Contract notional amount of foreign exchange forward contracts	$	133	$	110
Net contract notional amount of foreign exchange forward contracts	$	14	$	41
Contract notional amount of interest rate swap	$	400	$	413

All derivatives are recognized in the condensed consolidated balance sheets at their fair value. The notional amounts represent agreed-upon amounts on which calculations of dollars to be exchanged are based and are an indication of the extent of Teradata’s involvement in such instruments. These notional amounts do not represent amounts exchanged by the parties and, therefore, are not a measure of the instruments. Refer to Note 9 for disclosures related to the fair value of all derivative assets and liabilities.

The Company does not hold or issue derivative financial instruments for trading purposes, nor does it hold or issue leveraged derivative instruments. By using derivative financial instruments to hedge exposures to changes in foreign exchange and interest rates, the Company exposes itself to credit risk. The Company manages exposure to counterparty credit risk by entering into derivative financial instruments with highly rated institutions that can be expected to fully perform under the terms of the applicable contracts.

8. Commitments and Contingencies

Legal Proceedings. In the ordinary course of business, the Company is subject to proceedings, lawsuits, governmental investigations, claims and other matters, including those that relate to the environment, health and safety, employee benefits, export compliance, intellectual property, tax matters and other regulatory compliance and general matters. It is not currently a party to any litigation, nor is it aware of any pending or threatened litigation against it that the Company believes would materially affect its business, operating results, financial condition or cash flows, other than the following.

On June 19, 2018, the Company and certain of its subsidiaries filed a lawsuit (the "TD-SAP 1" suit) in the U.S. District Court for the Northern District of California against SAP SE, SAP America, Inc., and SAP Labs, LLC (collectively, "SAP"). In the TD-SAP 1 lawsuit, the Company alleged, among other things, that SAP misappropriated certain of the Company’s trade secrets within the Company’s enterprise data analytics and warehousing products and used such trade secrets to help develop, improve, introduce, and sell one or more

13

competing products. The Company further alleged that SAP employed anticompetitive practices using its substantial market position in the enterprise resource planning applications market to pressure the Company’s customers and prospective customers to use one or more of SAP's competing products and reduce or eliminate customers' and prospective customers' use of the Company's offerings. The Company sought an injunction barring SAP’s alleged conduct, monetary damages, and other available legal and equitable relief. In July 2019, SAP filed patent infringement counterclaims against the Company based on five of SAP’s U.S. patents. On August 31, 2020, the Company filed a second lawsuit against SAP (the "TD-SAP 2" suit) in the U.S. District Court for the Northern District of California, in which the Company alleged infringement by SAP of four of the Company's U.S. patents. On February 16, 2021, SAP filed additional patent infringement counterclaims against the Company in response. On the same day, SAP also filed a lawsuit in Germany (the "TD-SAP 3" suit) for infringement of a single German patent. In November 2021, the district court dismissed the Company’s antitrust claims and most of its trade secret claims in the TD-SAP 1 suit. In December 2021, the Company appealed that decision to the U.S. Court of Appeals for the Federal Circuit in Washington, D.C. In the meantime, the Company and SAP have entered into a partial settlement agreement that has resulted in full dismissal of all claims and counterclaims in the TD-SAP 2 suit in California and the TD-SAP 3 suit in Germany as well as a stay of all claims and counterclaims remaining in the TD-SAP 1 suit pending resolution of the Company’s appeal. Currently, it is not possible to determine the likelihood of a loss or a reasonably estimated range of loss, if any, pertaining to any of SAP’s remaining patent counterclaims in the TD-SAP 1 lawsuit.

Other Contingencies. The Company provides its customers with certain indemnification rights. In general, the Company agrees to indemnify the customer if a third party asserts patent or other infringement on the part of the customer for its use of the Company’s offerings. The Company has indemnification obligations under its charter and bylaws to its officers and directors, and has entered into indemnification agreements with the officers and directors of its subsidiaries. From time to time, the Company also enters into agreements in connection with its acquisition and divestiture activities that include indemnification obligations by the Company. The fair value of these indemnification obligations is typically not readily determinable due to the conditional nature of the Company’s potential obligations and the specific facts and circumstances involved with each particular agreement. As such, the Company has generally not recorded a liability in connection with these indemnification arrangements. Historically, payments made by the Company under these types of agreements have not had a material effect on the Company’s consolidated financial condition, results of operations or cash flows.

Concentrations of Risk. The Company is potentially subject to concentrations of credit risk on accounts receivable and financial instruments such as hedging instruments, and cash and cash equivalents. Credit risk includes the risk of nonperformance by counterparties. The maximum potential loss may exceed the amount recognized on the balance sheet. Exposure to credit risk is managed through credit approvals, credit limits, selecting major international financial institutions (as counterparties to hedging transactions) and monitoring procedures. Teradata’s business often involves large transactions with customers, and if one or more of those customers were to default in its obligations under applicable contractual arrangements, the Company could be exposed to potentially significant losses. However, management believes that the reserves for potential losses were adequate at March 31, 2022 and December 31, 2021.

The Company is also potentially subject to concentrations of supplier risk. Our hardware components are assembled exclusively by Flex Ltd. ("Flex"). Flex procures a wide variety of components used in the manufacturing process on behalf of the Company. Although many of these components are available from multiple sources, Teradata utilizes preferred supplier relationships to provide more consistent and optimal quality, cost and delivery. Typically, these preferred suppliers maintain alternative processes and/or facilities to ensure continuity of supply. Given the Company’s strategy to outsource its manufacturing activities to Flex and to source certain components from single suppliers, a disruption in production at Flex or at a supplier could impact the timing of customer shipments and/or Teradata’s operating results. In addition, a significant change in the forecasts to any of these preferred suppliers could result in purchase obligations for components that may be in excess of demand.

14

9. Fair Value Measurements

Fair value measurements are established utilizing a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. These tiers include: Level 1, defined as observable inputs such as quoted prices in active markets for identical assets or liabilities; Level 2, defined as significant other observable inputs, such as quoted prices in active markets for similar assets or liabilities, or quoted prices in less-active markets for identical assets; and Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions. Financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.

The Company’s assets and liabilities measured at fair value on a recurring basis include money market funds, interest rate swaps and foreign currency exchange contracts. A portion of the Company’s excess cash reserves are held in money market funds which generate interest income based on the prevailing market rates. Money market funds are included in cash and cash equivalents in the Company’s balance sheet. Money market fund holdings are measured at fair value using quoted market prices and are classified within Level 1 of the valuation hierarchy.

When deemed appropriate, the Company minimizes its exposure to changes in foreign currency exchange rates through the use of derivative financial instruments, specifically, foreign exchange forward contracts. Additionally, in June 2018, Teradata executed a five-year interest rate swap with a $500 million initial notional amount in order to hedge the floating interest rate on its term loan. The fair value of these contracts and swaps are measured at the end of each interim reporting period using observable inputs other than quoted prices, specifically market spot and forward exchange rates. As such, these derivative instruments are classified within Level 2 of the valuation hierarchy. Fair value of unrealized gains for open contracts are recorded in other assets and the fair value of unrealized losses are recorded in other liabilities in the Company's balance sheet. The fair value of foreign exchange forward contract assets and liabilities at March 31, 2022 and December 31, 2021 was not material. Realized gains and losses from the Company’s fair value hedges net of corresponding gains or losses on the underlying exposures were immaterial for the three months ended March 31, 2022 and 2021.

The Company’s other assets and liabilities measured at fair value on a recurring basis and subject to fair value disclosure requirements at March 31, 2022 and December 31, 2021 were as follows:

			Fair Value Measurements at Reporting Date Using
In millions	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Assets
Money market funds at March 31, 2022	$	84	$	84	$	—	$	—
Money market funds at December 31, 2021	$	148	$	148	$	—	$	—
Liabilities
Interest rate swap at March 31, 2022	$	4	$	—	$	4	$	—
Interest rate swap at December 31, 2021	$	12	$	—	$	12	$	—

10. Debt

In June 2018, Teradata replaced an existing 5 year, $400 million revolving credit facility with a new $400 million revolving credit facility (the "Credit Facility"). The Credit Facility expires in June 2023, at which point any remaining outstanding borrowings would be due for repayment unless extended by agreement of the parties for up to two additional one-year periods. In addition, under the terms of the Credit Facility, Teradata from time to time and subject to certain conditions may increase the lending commitments under the Credit Facility in an aggregate principal amount up to an additional $200 million, to the extent that existing or new lenders agree to provide such additional commitments. The outstanding principal amount of the Credit Facility bears interest at a floating rate based upon, at Teradata’s option, a negotiated base rate or a Eurodollar rate plus, in each case, a margin based on Teradata’s leverage ratio. In the near term, Teradata would anticipate choosing a floating rate based on LIBOR. The

15

Credit Facility is unsecured but is guaranteed by certain of Teradata’s material domestic subsidiaries and contains certain representations and warranties, conditions, affirmative, negative and financial covenants, and events of default customary for such facilities. As of March 31, 2022, the Company had no borrowings outstanding under the Credit Facility, leaving $400 million in borrowing capacity available under the Credit Facility. The Company was in compliance with all covenants under the Credit Facility as of March 31, 2022.

Also, in June 2018, Teradata closed on a senior unsecured $500 million five-year term loan, the proceeds of which plus additional cash-on-hand were used to pay off the remaining $525 million of principal on its previous term loan. The term loan is payable in quarterly installments, which commenced on June 30, 2019, with 1.25% of the initial principal amount due on each of the first eight payment dates; 2.50% of the initial principal amount due on each of the next four payment dates; 5.0% of the initial principal amount due on each of the next three payment dates; and all remaining principal due in June 2023. The outstanding principal amount of the term loan bears interest at a floating rate based upon a negotiated base rate or a Eurodollar rate, plus in each case, a margin based on the leverage ratio of the Company. As of March 31, 2022, the term loan principal outstanding was $400 million. As disclosed in Note 7, Teradata entered into an interest rate swap to hedge the floating interest rate of the term loan. As a result of the swap, Teradata’s fixed rate on the term loan equals 2.86% plus the applicable leverage-based margin as defined in the term loan agreement. As of March 31, 2022, the all-in fixed rate is 4.23%. The Company was in compliance with all covenants under the term loan as of March 31, 2022.

Teradata’s term loan is recognized on the Company’s balance sheet at its unpaid principal balance, net of deferred issuance costs, and is not subject to fair value measurement. However, given that the loan carries a variable rate, the Company estimates that the unpaid principal balance of the term loan would approximate its fair value. If measured at fair value in the financial statements, the Company’s term loan would be classified as Level 2 in the fair value hierarchy.

11. Earnings per Share

Basic earnings per share is calculated by dividing net income by the weighted average number of shares outstanding during the reported period. The calculation of diluted earnings per share is similar to basic earnings per share, except that the weighted average number of shares outstanding includes the dilution from potential shares resulting from stock options, restricted stock awards and other stock awards. The components of basic and diluted earnings per share are as follows:

	Three Months Ended March 31,
In millions, except per share amounts	2022		2021
Net income attributable to common stockholders	$	36	$	53
Weighted average outstanding shares of common stock	105.0		108.7
Dilutive effect of employee stock options, restricted stock and other stock awards	3.6		4.1
Common stock and common stock equivalents	108.6		112.8
Net income per share:
Basic	$	0.34	$	0.49
Diluted	$	0.33	$	0.47

Options to purchase 0.1 million shares of common stock for the three months ended March 31, 2022 and 1.2 million shares of common stock for the three months ended March 31, 2021 were not included in the computation of diluted earnings per share because the exercise prices of these options were greater than the average market price of the common shares for the period, and therefore would have been anti-dilutive.

Accelerated Share Repurchase Agreement ("ASR")

On February 9, 2022 Teradata entered into an ASR agreement with JPMorgan Chase Bank, National Association ("JPMorgan Chase") to purchase shares of its common stock from JPMorgan Chase for an aggregate purchase price of $250 million. Pursuant to the ASR, the Company received an initial delivery of 3,930,045 shares of common stock based on the $50.89 closing price of the common stock on February 8, 2022. As a result, approximately $50 million remains at JPMorgan Chase for additional repurchases until the completion of the ASR. The ASR

16

agreement was entered into pursuant to the Company's open market share repurchase authorization as discussed in the Financial Condition, Liquidity and Capital Resources section of Item 2 in this Quarterly Report on Form 10-Q. The final number of shares that will be delivered to Teradata under the ASR will be based on the average of the daily volume-weighted average trading prices of Teradata’s common stock during the term of the ASR, less a discount. The Company expects to receive the remaining shares no later than August 9, 2022. The effect of the potential share settlement is excluded in the diluted EPS calculation as the effect is anti-dilutive.

12. Segment and Other Supplemental Information

Teradata manages its business under three geographic regions, which are also the Company’s operating segments: (1) Americas region (North America and Latin America); (2) EMEA region (Europe, Middle East and Africa) and (3) APJ region (Asia Pacific and Japan). For purposes of discussing results by segment, management excludes the impact of certain items, consistent with the manner by which management evaluates the performance of each segment. This format is useful to investors because it allows analysis and comparability of operating trends. It also includes the same information that is used by Teradata management to make decisions regarding the segments and to assess financial performance. The chief operating decision maker, who is the Company's President and Chief Executive Officer, evaluates the performance of the segments based on revenue and multiple profit measures, including segment gross profit. For management reporting purposes, assets are not allocated to the segments.

The following table presents segment revenue and segment gross profit for the Company:

	Three Months Ended March 31,
In millions	2022		2021
Segment revenue
Americas	$	290	$	263
EMEA	129		147
APJ	77		81
Total revenue	496		491
Segment gross profit
Americas	189		182
EMEA	78		88
APJ	45		45
Total segment gross profit	312		315
Stock-based compensation costs	5		3
Acquisition, integration, reorganization and transformation-related costs	6		5
Total gross profit	301		307
Selling, general and administrative expenses	157		149
Research and development expenses	76		77
Income from operations	$	68	$	81

17

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations ("MD&A").

You should read the following discussion in conjunction with the Condensed Consolidated Financial Statements and the notes to those statements included elsewhere in this Quarterly Report on Form 10-Q. This Quarterly Report on Form 10-Q contains certain statements that are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. Certain statements contained in the MD&A are forward-looking statements that involve risks and uncertainties. The forward-looking statements are not historical facts, but rather are based on current expectations, estimates, assumptions and projections about our industry, business and future financial results. Our actual results could differ materially from the results contemplated by these forward-looking statements due to a number of factors, including those discussed in other sections of this Quarterly Report on Form 10-Q and in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021 (the "2021 Annual Report"). The Company does not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Overview

Teradata Corporation ("we," "us," "Teradata," or the "Company") is a provider of a leading connected multi-cloud data platform for enterprise analytics, focused on helping companies leverage all their data across an enterprise, at scale. In doing so, we help companies to find answers to their toughest business challenges. All of our efforts are in support of our purpose of transforming how businesses work and people live through the power of data. Our platform is composed of our data platform — Teradata Vantage — which is designed to run across on-premises, private cloud and public cloud environments. This platform is supported by business consulting and support services that enable customers to extract insights from across a company’s entire data and analytics ecosystem.

We are continuing to execute on our key priorities, including product expansion of our Teradata Vantage multi-cloud data platform offering, expanding our business with existing customers and adding new customers, increasing our focus on sustainability and diversity, equity, and inclusion, and driving operational excellence and agility across the company.

To allow for greater transparency regarding the progress we are making toward achieving our strategic objectives, we utilize the following financial and performance metrics:

•Annual Recurring Revenue ("ARR") - annual value at a point in time of all contracts, including subscription, cloud, software upgrade rights, and maintenance. ARR does not include managed services and third-party revenue.

•Public Cloud ARR (included within total ARR) - annual value at a point in time of all recurring contracts related to public cloud implementations of Teradata Vantage and does not include ARR related to private or managed cloud implementations.

•Cloud Net Expansion Rate - Teradata calculates its last-twelve months dollar-based cloud net expansion rate as of a fiscal quarter end as follows:

◦Identify ARR for active cloud customers in the fiscal quarter ending one year prior to the given fiscal quarter (the "base period");

◦Identify public cloud ARR in the given fiscal quarter (the "current period") from the same set of active cloud customers as the base period, including increases in usage, as well as reductions and cancellations, and additional conversions of on-premises revenues to the cloud for customers active in the base period, all in constant currency;

◦Cloud net expansion rate is calculated by taking the ARR from the current period and dividing by the ARR from the base period (all quarterly-dollar based); and

18

◦The last twelve-month dollar-based cloud net expansion rate is calculated by taking the average of the quarterly dollar-based cloud net expansion rate from the last fiscal quarter and the prior three fiscal quarters.

COVID-19 Update

See Part I, Item 1A. "Risk Factors" and Part II, Item 7, "Management's Discussion and Analysis of Financial Condition and Results of Operations" in the 2021 Annual Report for a discussion related to risks and impact of COVID-19 on the Company. As of the date of this Quarterly Report on Form 10-Q, we are continuing to execute our pandemic response plan, and the Teradata Pandemic Response Team is refining and executing return-to-office plans. Under our return-to-office plans, none of our employees are required to return to an office environment and can choose to continue to work remotely or under a hybrid model. For employees choosing to return to the office environment, certain safety protocols will be required to be followed. Customer-facing teams are also proactively working to identify ways to assist customers, meet service level commitments, and engage with customers via virtual events if requested by our customers.

First Quarter Financial Overview

As more fully discussed in later sections of this MD&A, the following were significant financial items for the first quarter of 2022:

•At the end of the first quarter of 2022, ARR was $1.427 billion compared to $1.404 billion in the first quarter of 2021, increasing 2% as compared to the first quarter of 2021, including a 1% adverse impact from foreign currency translation.

•At the end of first quarter of 2022, Public Cloud ARR was $209 million compared to $124 million in the first quarter of 2021, increasing 69% as compared to the first quarter of 2021, including a 1% adverse impact from foreign currency fluctuations.

•Total revenue was $496 million for the first quarter of 2022, a 1% increase compared to the first quarter of 2021, with an underlying 4% increase in recurring revenue. Perpetual software licenses, hardware and other revenue increased 13%, and consulting services revenue decreased 13%. Foreign currency fluctuations had a 3% adverse impact on total revenue for the quarter compared to the prior year.

•Gross margin decreased to 60.7% in the first quarter of 2022 from 62.5% in the first quarter of 2021, primarily due to expenses incurred as a result of ceasing operations in Russia, and the adverse impact of foreign currency fluctuations.

•Operating expenses for the first quarter of 2022 increased by 3% compared to the first quarter of 2021, primarily due to higher stock-based compensation and expenses incurred in ceasing our operations in Russia.

•Operating income was $68 million in the first quarter of 2022, compared to $81 million in the first quarter of 2021.

•Net income in the first quarter of 2022 was $36 million, compared to net income of $53 million in the first quarter of 2021.

•Cloud Net Expansion Rate for the first quarter of 2022 was approximately 130%.

19

Results of Operations for the Three Months Ended March 31, 2022

Compared to the Three Months Ended March 31, 2021

Revenue and ARR

			% of				% of
In millions	2022		Revenue		2021		Revenue
Recurring	$	386	77.9	%	$	372	75.7	%
Perpetual software licenses, hardware and other	26		5.2	%	23		4.7	%
Consulting services	84		16.9	%	96		19.6	%
Total revenue	$	496	100	%	$	491	100	%

Total revenue increased $5 million, or 1%, in the first quarter of 2022. Total revenue was adversely impacted by the loss of approximately $10 million in revenue (a significant majority related to recurring revenue) as a result of our ceasing operations in Russia during the first quarter of 2022 in support of sanctions imposed because of Russia's invasion of Ukraine. Total revenue growth was primarily driven by a higher mix of recurring revenue. As a percentage of total revenue, recurring revenue was 78% in the first quarter, which reflects growth of 4%, including a 2% negative impact from foreign currency fluctuations. On-premises customer transactions involving substantive long-term commitments resulted in revenue being recognized on a recurring annual basis rather than a recurring quarterly basis resulting in approximately 1% of net positive impact to recurring revenue in the first quarter of 2022 compared to the first quarter of 2021.

At the end of the first quarter of 2022, ARR was $1.427 billion compared to $1.404 billion in the first quarter of 2021, increasing 2% as compared to the first quarter of 2021, including a 1% adverse impact from foreign currency translation. The 2% increase in Total ARR includes the reduction we realized during the first quarter of 2022 upon deciding to cease operations in Russia during the quarter. As the Russia business was primarily on-premises, ceasing our operations in Russia resulted in minimal impact to Public Cloud ARR. At the end of first quarter of 2022, Public Cloud ARR was $209 million compared to $124 million in the first quarter of 2021, increasing 69% as compared to the first quarter of 2021, including a 1% adverse impact from foreign currency fluctuations. Public Cloud ARR grew in all three geographic regions year-over-year. Public Cloud ARR growth in the first quarter of 2022 was driven primarily by expansions of existing customers. We experienced expansion activity from a high number of customers, both new (migrations from on-premises) and existing cloud customers. Many of these customers are adding new workloads onto our Vantage cloud platform while also maintaining hybrid environments on Teradata. We also continue to see new logo customers, both on-premises and in the cloud, which grew year-over-year.

Revenues from perpetual software licenses, hardware and other were up 13% in the first quarter of 2022, including a 4% negative impact from foreign currency fluctuations, primarily due to the timing of deals and a low prior year comparison.

Consulting services revenue decreased 13% in the first quarter of 2022, including a 4% adverse impact from foreign currency, primarily due to our continued realignment of our consulting resources on higher-margin engagements, both direct engagement with customers and joint engagement with partners that drive increased software consumption within our targeted customer base.

Upon deciding to cease operations in Russia during the first quarter of 2022, we removed anticipated contributions for the partial period from our first quarter results and from the projections for the remainder of 2022. In addition, the recent strengthening of the U.S. dollar is expected to have an adverse impact on the prior guidance we provided. As a result of ceasing our operations in Russia and the expected adverse impact of currency rates, we anticipate the following for full year 2022 outlook:

•Total ARR is now projected to decline in the low-single-digit percentage range year-over-year as reported, which includes the anticipated $55 million reduction of ARR related to ceasing operations in Russia.

•Public Cloud ARR is expected to increase by approximately 80% year-over-year as reported.

•Recurring revenue is anticipated to decline in the low-to-mid-single-digit percentage range year-over year as reported.

20

•Taking into consideration the full year 2022 total revenue impact of approximately $60 million related to ceasing operations in Russia, total revenue is now expected to decline in the mid-to-high-single-digit percentage range year-over-year as reported.

As a portion of the Company’s operations and revenue occur outside the United States, and in currencies other than the U.S. dollar, the Company is exposed to fluctuations in foreign currency exchange rates. Based on currency rates as of April 29, 2022, Teradata is estimating a 3.5%-to-4.0% negative impact from currency translation on our 2022 full-year total reported revenues.

21

Gross Profit

			% of				% of
In millions	2022		Revenue		2021		Revenue
Recurring	$	281	72.8	%	$	282	75.8	%
Perpetual software licenses, hardware and other	8		30.8	%	12		52.2	%
Consulting services	12		14.3	%	13		13.5	%
Total gross profit	$	301	60.7	%	$	307	62.5	%

The decrease in recurring revenue gross profit as a percentage of revenue was primarily driven by a loss of recurring revenue as a result of ceasing operations in Russia and the negative effect of foreign currency exchange rates, partially offset by a higher mix of subscription-based revenue and the positive impact of upfront revenue arrangements in the first quarter of 2022.

The decrease in perpetual software licenses, hardware and other gross profit as a percentage of revenue was primarily driven by deal mix.

Consulting services gross profit as a percentage of revenue increased as compared to the prior year primarily due to our continued strategic focus on higher-value projects.

Operating Expenses

			% of				% of
In millions	2022		Revenue		2021		Revenue
Selling, general and administrative expenses	$	157	31.7	%	$	149	30.3	%
Research and development expenses	76		15.3	%	77		15.8	%
Total operating expenses	$	233	47.0	%	$	226	46.0	%

The selling, general and administrative expense ("SG&A") increase was primarily driven by investments in cloud and go-to-market operations, higher stock-based compensation and expenses incurred in connection with ceasing our operations in Russia, which was partially offset by continued cost discipline and actions to adjust our cost structure for the unplanned closure of our operations in Russia. Research and development ("R&D") expense was relatively flat year-over-year.

Other Expense, net

In millions	2022		2021
Interest income	$	2	$	1
Interest expense	(6)		(7)
Other	(9)		(3)
Other expense, net	$	(13)	$	(9)

Other expense, net in the first quarter of 2022 and 2021 is comprised primarily of interest expense on long-term debt and finance leases, losses resulting from foreign currency transactions, as well as benefit costs on our pension and postemployment plans, partially offset by interest income earned on our cash and cash equivalents.

Provision for Income Taxes

Income tax provisions for interim periods are based on estimated annual income tax rates, adjusted to reflect the effects of any significant infrequent or unusual items which are required to be discretely recognized within the current interim period.

The effective tax rate for the three months ended March 31, 2022 and 2021 were as follows:

	2022		2021
Effective tax rate	34.5	%	26.4	%

22

For the three months ended March 31, 2022, we recorded a total of $4 million of net discrete tax benefits, a majority of which related to the excess tax benefit derived from stock-based compensation vesting. In addition, our effective tax rate increased by 9% as a result of the forecasted GILTI tax liability, which increased as a result of the requirement in the U.S. to capitalize and amortize R&D for tax purposes, that became effective on January 1, 2022.

For the three months ended March 31, 2021, we recorded $3 million of discrete tax benefit, a majority of which related to the excess tax benefit derived from stock compensation vesting.

Effective on January 1, 2022, the U.S. tax law changed and now requires R&D expenses to be capitalized and amortized for tax purposes under Internal Revenue Code Section 174; as a result of this law change, the Company is currently forecasting approximately $12 million of tax expense related to GILTI in our marginal effective tax rate for 2022. Should Congress enact proposed legislation to defer the implementation of R&D capitalization rules retroactively by the end of the year, the Company’s GILTI tax and overall effective tax rate for 2022 would be significantly reduced. We expect that a majority of our foreign earnings will be repatriated to the U.S. As a result, the effective tax rates in the periods presented are largely based upon the forecasted pre-tax earnings mix between the U.S. and other foreign taxing jurisdictions where we conduct our business. We estimate that the full-year effective tax rate for 2022 will be approximately 37%, which takes into consideration, among other things, the forecasted earnings mix by jurisdiction, the estimated impact to GILTI tax as a result of the requirement to capitalize R&D for tax purposes, and the estimated discrete items to be recognized in 2022. The forecasted tax rate is based on the overseas profits being taxed at an overall effective tax rate of approximately 23%, as compared to the U.S. federal statutory tax rate of 21%.

Revenue and Gross Profit by Operating Segment

Teradata manages its business under three geographic regions, which are also our operating segments: (1) Americas region (North America and Latin America); (2) EMEA region (Europe, Middle East, and Africa) and (3) APJ region (Asia Pacific and Japan). For purposes of discussing results by segment, management excludes the impact of certain items, consistent with the manner by which management evaluates the performance of each segment. This format is useful to investors because it allows analysis and comparability of operating trends. It also includes the same information that is used by our management to make decisions regarding the segments and to assess financial performance. The chief operating decision maker, who is our President and Chief Executive Officer, evaluates the performance of the segments based on revenue and multiple profit measures, including segment gross profit. For management reporting purposes, assets are not allocated to the segments. Our segment results are reconciled to total company results reported under GAAP in Note 12 of Notes to Condensed Consolidated Financial Statements (Unaudited).

The following table presents segment revenue and segment gross profit for the Company for the three months ended March 31:

			% of				% of
In millions	2022		Revenue		2021		Revenue
Segment revenue
Americas	$	290	58.5	%	$	263	53.6	%
EMEA	129		26.0	%	147		29.9	%
APJ	77		15.5	%	81		16.5	%
Total segment revenue	$	496	100	%	$	491	100	%
Segment gross profit
Americas	$	189	65.2	%	$	182	69.2	%
EMEA	78		60.5	%	88		59.9	%
APJ	45		58.4	%	45		55.6	%
Total segment gross profit	$	312	62.9	%	$	315	64.2	%

Americas

Americas revenue increased 10% as compared to the prior year, including a 1% adverse impact from foreign currency fluctuations. Recurring revenue was up 13% and perpetual and other revenue was up 71% ($5 million).

23

Consulting revenue decreased 16% as compared to the prior year. Segment gross profit as a percentage of revenues was lower primarily due to a higher mix of public cloud revenue and costs.

EMEA

EMEA revenue decreased 12%, which included a 6% adverse impact from foreign currency fluctuations. The overall decrease in EMEA revenue included a decrease of 12% in recurring revenue, a decrease of 15% ($2 million) in perpetual and other revenue and a decrease of 12% in consulting revenue. EMEA revenue was negatively impacted by our ceasing operations in Russia during the first quarter of 2022 in support of the sanctions imposed because of Russia's invasion of Ukraine. Segment gross profit as a percentage of revenues was higher primarily due to a higher mix of recurring revenue.

APJ

APJ revenue decreased 5%, including a 5% adverse impact from foreign currency fluctuations. Recurring revenue decreased by 4% and consulting revenue decreased by 8%. Segment gross profit as a percentage of revenues was higher primarily due to a higher mix of recurring revenue.

24

Financial Condition, Liquidity and Capital Resources

Cash provided by operating activities was $151 million, which increased by $41 million in the three months ended March 31, 2022 compared to the three months ended March 31, 2021. The increase in cash provided by operating activities was primarily due to better cash conversion efficiency due to favorable working capital dynamics, primarily due to strong collections of receivables. In addition, we received a $50 million tax refund related to our Cares Act carryback claim. Teradata used approximately $10 million of cash in the first three months of 2022 for reorganizing and restructuring its operations and go-to-market functions to align to its strategy, as compared to $19 million in the first three months of 2021.

Teradata’s management uses a financial measure called "free cash flow," which is not a measure defined under GAAP. We use free cash flow (which we define as net cash provided by operating activities less investing activities related to capital expenditures for property and equipment and additions to capitalized software) as one measure of assessing the financial performance of the Company, and this may differ from the definitions used by other companies. The components that are used to calculate free cash flow are GAAP measures taken directly from the Condensed Consolidated Statements of Cash Flows (Unaudited). We believe that free cash flow information is useful for investors because it relates the operating cash flow of the Company to the capital that is spent to continue and improve business operations. In particular, free cash flow indicates the amount of cash available after capital expenditures, for among other things, investments in the Company’s existing businesses, strategic acquisitions and repurchases of Teradata common stock. Free cash flow does not represent the residual cash flow available for discretionary expenditures since there may be other non-discretionary expenditures that are not deducted from the measure. This non-GAAP measure should not be considered a substitute for, or superior to, cash flows from operating activities under GAAP.

The table below shows net cash provided by operating activities and net cash used in investing activities related to capital expenditures, along with free cash flow, for the following periods:

	Three Months Ended March 31, 2022
In millions	2022		2021
Net cash provided by operating activities	$	151	$	110
Less:
Expenditures for property and equipment	(1)		(4)
Additions to capitalized software	—		(1)
Free cash flow	$	150	$	105

Financing activities and certain other investing activities are not included in our calculation of free cash flow. There were no other investing activities for the three months ended March 31, 2022 and 2021.

Teradata’s financing activities for the three months ended March 31, 2022 and 2021 primarily consisted of cash outflows for share repurchases and payments on our finance leases and long-term debt. At March 31, 2022, we had no outstanding borrowings on our $400 million revolving credit facility entered into in June 2018 (the "Credit Facility").

As to share repurchases, we have two share repurchase programs that were authorized by our Board of Directors:

•The dilution offset share repurchase program allows us to repurchase Teradata common stock to the extent (i) cash is received from the exercise of stock options and (ii) employees purchase Teradata stock pursuant to the Teradata Employee Stock Purchase Plan ("ESPP"). The purpose of the dilution offset share repurchase program is to offset dilution from shares issued pursuant to the exercise of stock options and shares purchased under the ESPP.

25

•Our open market share repurchase program provides for the repurchase of Teradata stock periodically on an ongoing basis in open market transactions, through 10b5-1 programs, through accelerated share repurchase programs, in privately negotiated transactions, or through the use of derivative instruments, in accordance with applicable securities rules regarding issuer repurchases. The open market share repurchase program will expire on December 31, 2025. On November 1, 2021, our Board of Directors authorized an additional $1 billion for share repurchases under the open market share repurchase program and on February 9, 2022 we entered into an accelerated share repurchase agreement ("ASR") with JPMorgan Chase Bank, National Association ("JPMorgan Chase") to purchase shares of Teradata common stock from JPMorgan Chase for an aggregate purchase price of $250 million. After giving effect to the ASR, but excluding approximately $50 million which remains at JPMorgan Chase for additional repurchases until the completion of the ASR, there is a total authority of $963 million remaining under the open market share repurchase program as of March 31, 2022.

In the aggregate under the dilution offset share repurchase program, the open market share repurchase program and the ASR, we repurchased approximately 5.1 million shares of common stock at an average price per share of $48.85 in the three months ended March 31, 2022 (which includes the initial delivery of Teradata common stock under the ASR of approximately 3.9 million shares based on the closing price of the common stock of $50.89 on February 8, 2022), and 2.6 million shares at an average price per share of $32.94 in the three months ended March 31, 2021. Share repurchases are reported on a trade date basis. Our share repurchase activity depends on factors such as our working capital needs, our cash requirements for capital investments, our stock price, and economic and market conditions.

Proceeds from the ESPP and the exercise of stock options, net of tax, were $4 million for the three months ended March 31, 2022 and $13 million for the three months ended March 31, 2021. These proceeds are included in other financing activities, net in the Condensed Consolidated Statements of Cash Flows (Unaudited).

Our total cash and cash equivalents held outside the United States in various foreign subsidiaries was $348 million as of March 31, 2022 and $401 million as of December 31, 2021. The remaining balance held in the United States ("U.S.") was $56 million as of March 31, 2022 and $191 million as of December 31, 2021. The Company considers a majority of its foreign earnings will be repatriated to the U.S. Effective January 1, 2018, the U.S. moved to a territorial system of international taxation, and as such will generally not subject future foreign earnings to U.S. taxation upon repatriation in future years.

Management believes current cash, cash generated from operations and the $400 million available under the Credit Facility will be sufficient to satisfy future working capital, research and development activities, capital expenditures, pension contributions, and other financing requirements for at least the next twelve months. The Company principally holds its cash and cash equivalents in bank deposits and highly-rated money market funds.

The Company’s ability to generate positive cash flows from operations is dependent on general economic conditions, competitive pressures, and other business and risk factors described in the 2021 Annual Report and elsewhere in this Quarterly Report on Form 10-Q. If the Company is unable to generate sufficient cash flows from operations, or otherwise comply with the terms of the Credit Facility or its term loan agreement, the Company may be required to seek additional financing alternatives.

Long-term Debt. There has been no significant change in our long-term debt as described in the 2021 Annual Report. Our long-term debt is discussed in Note 10 of Notes to Condensed Consolidated Financial Statements (Unaudited).

Contractual and Other Commercial Commitments. There has been no significant change in our contractual and other commercial commitments as described in the 2021 Annual Report. Our commitments and contingencies are discussed in Note 8 of Notes to Condensed Consolidated Financial Statements (Unaudited).

Critical Accounting Policies and Estimates

Our financial statements are prepared in accordance with GAAP. In connection with the preparation of these financial statements, we are required to make assumptions, estimates and judgments that affect the reported amounts of assets, liabilities, revenues, expenses and the related disclosure of contingent liabilities. These assumptions, estimates and judgments are based on historical experience and assumptions that are believed to be reasonable at the time. However, because future events and their effects cannot be determined with certainty, the determination of

26

estimates requires the exercise of judgment. Our critical accounting policies are those that require assumptions to be made about matters that are highly uncertain. Different estimates could have a material impact on our financial results. Judgments and uncertainties affecting the application of these policies and estimates may result in materially different amounts being reported under different conditions or circumstances. Our management periodically reviews these estimates and assumptions to ensure that our financial statements are presented fairly and are materially correct. We assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to us as of March 31, 2022 and through the date of this report. The accounting matters assessed included, but were not limited to, our allowance for doubtful accounts, stock-based compensation, the carrying value of our goodwill and other long-lived assets, financial assets, valuation allowances for tax assets and revenue recognition.

In many cases, the accounting treatment of a particular transaction is specifically dictated by GAAP and does not require significant management judgment in its application. There are also areas in which management’s judgment in selecting among available alternatives would not produce a materially different result. The significant accounting policies and estimates that we believe are the most critical to aid in fully understanding and evaluating our reported financial results are discussed in the 2021 Annual Report. Teradata’s senior management has reviewed these critical accounting policies and related disclosures and determined that there were no significant changes in our critical accounting policies in the three months ended March 31, 2022.

New Accounting Pronouncements

See discussion in Note 2 of Notes to Condensed Consolidated Financial Statements (Unaudited) for new accounting pronouncements.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

There have not been any material changes to the market risk factors previously disclosed in Part II, Item 7A of the 2021 Annual Report.

27

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

Teradata maintains a system of disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the "Exchange Act")) that are designed to provide reasonable assurance that information required to be disclosed in its reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to management, including, as appropriate, the Chief Executive Officer and the Chief Financial Officer, to allow timely decisions regarding required disclosures. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives.

Based on their evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of March 31, 2022, our disclosure controls and procedures were effective to provide reasonable assurance that the information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

There have been no changes in our internal control over financial reporting that occurred during the fiscal quarter ended March 31, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. We have not experienced any material adverse impact to our internal controls over financial reporting as a result of most of our employees working remotely due to the COVID-19 pandemic. We are continually monitoring and assessing the COVID-19 situation on our internal controls to minimize the impact on their design and operating effectiveness.

Part II—OTHER INFORMATION

Item 1. Legal Proceedings.

The information required to be set forth under this Part II, Item 1 is incorporated by reference to Note 8, Commitments and Contingencies—Legal Proceedings of the Notes to Condensed Consolidated Financial Statements (Unaudited) included in this Quarterly Report on Form 10-Q.

Item 1A. Risk Factors.

There have not been any material changes to the risk factors previously disclosed in Part I, Item IA of the 2021 Annual Report.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

Purchases of Company Common Stock

From time to time, the Company's Section 16 officers sell to the Company shares of the Company's common stock received upon vesting of restricted share units at the current market price to cover their withholding tax obligations. For the three months ended March 31, 2022, the total of these purchases was 82,412 shares at an average price of $44.83 per share.

28

The following table provides information relating to the Company’s share repurchase programs for the three months ended March 31, 2022:

	Total Number of Shares Purchased	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Dilution Offset Program (1)	Total Number of Shares Purchased as Part of Publicly Announced Open Market Share Repurchase Program (2)	Maximum Dollar Value that May Yet Be Purchased Under the Dilution Offset Program		Maximum Dollar Value that May Yet Be Purchased Under the Open Market Share Repurchase Program
Month
January 2022	1,187,816	$	42.09	—	1,187,816	$	522,134	$	1,162,770,562
February 2022	3,930,045	$	50.89	—	3,930,045	$	1,174,757	$	962,770,572
March 2022	—	$	—	—	—	$	7,532,006	$	962,770,572
First Quarter Total	5,117,861	$	48.85	—	5,117,861	$	7,532,006	$	962,770,572

(1) The dilution offset share repurchase program allows the Company to repurchase Teradata common stock to the extent of cash received from the exercise of stock options and purchases under the ESPP to offset dilution from shares issued pursuant to these plans.

(2) The open market share repurchase program authorized by the Board allows the Company to repurchase outstanding shares of Teradata common stock. Share repurchases made by the Company are reported on a trade date basis. The open market share repurchase program expires on December 31, 2025.

Accelerated Share Repurchase Agreement ("ASR")

On February 9, 2022 we entered into an ASR agreement with JPMorgan Chase Bank, National Association ("JPMorgan Chase") to purchase shares of our common stock from JPMorgan Chase for an aggregate purchase price of $250 million. Pursuant to the ASR, we received an initial delivery of 3,930,045 shares of common stock based on the closing price of the common stock of $50.89 on February 8, 2022. As a result, approximately $50 million remains at JPMorgan Chase for additional repurchases until the completion of the ASR. The ASR agreement was entered into pursuant to our open market share repurchase authorization. The final number of shares that will be delivered to Teradata under the ASR will be based on the average of the daily volume-weighted average trading prices of Teradata’s common stock during the term of the ASR, less a discount. We expect to receive the remaining shares no later than August 9, 2022.

Item 3. Defaults Upon Senior Securities.

None

Item 4. Mine Safety Disclosures.

None

Item 5. Other Information.

None

29

Item 6. Exhibits.

Exhibit Number per Item 601 of Regulation S-K	Description
3.1	Amended and Restated Certificate of Incorporation of Teradata Corporation as amended and restated on September 24, 2007 (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K dated September 25, 2007 (SEC file number 001-33458)).
3.2	Amended and Restated By-Laws of Teradata Corporation, as amended and restated on July 26, 2016 (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K dated August 1, 2016).
4.1	Common Stock Certificate of Teradata Corporation (incorporated by reference to Exhibit 4.1 to the Quarterly Report on Form 10-Q dated November 13, 2007 (SEC file number 001-33458)).
10.1*	Amendment to Offer Letter between Stephen McMillan and the Company dated April 29, 2022
31.1	Certification pursuant to Rule 13a-14(a), dated May 6, 2022.
31.2	Certification pursuant to Rule 13a-14(a), dated May 6, 2022.
32	Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, dated May 6, 2022.
101.INS	Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document.
101.SCH	Inline XBRL Taxonomy Extension Schema Document
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document
104	Cover page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

* Management contract or compensatory plan, contract or arrangement.

30

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	TERADATA CORPORATION
Date: May 6, 2022	By:	/s/ Claire Bramley
		Claire Bramley Chief Financial Officer

31

EX-10.1

Exhibit 10.1

April 28, 2022

Steve McMillan

17095 Via del Campo

San Diego, CA 92127

Dear Steve,

As you know, Teradata has implemented a hybrid/virtual workplace model and revised its travel allowance policy for executives. As a result, employees who live outside the San Diego area will not be required to relocate to the San Diego office and their primary work location will be their home office. Effective March 1, 2022, your home office is your primary work location, revising your offer letter dated May 5, 2020.

Additionally, the Compensation and Human Resource Committee (“Compensation Committee”) of the Teradata Board of Directors has adopted an Executive Travel Allowance Policy to facilitate executive travel from their home office to Teradata’s San Diego headquarters as needed. As a result, effective March 1, 2022, your gross monthly allowance has been revised to reflect the Executive Travel Allowance Policy amount for the Chief Executive Officer of $12,500, subject to applicable taxes, to cover the cost of lodging and for rental car, or ride services, to and from the office. Airfare to/from the San Diego office will be treated as a business expense and reimbursed according to Teradata’s Travel and Expense policy. This allowance will be treated as taxable compensation to you but will not be considered part of your normal or expected compensation for purposes of calculating severance payments, bonuses, long-service awards, or retirement benefits or similar payments. Teradata shall have no other obligations to reimburse you for any costs related to these expenses, nor will it assume any liability for lease agreements should you wish to lease an apartment. The section of your offer letter entitled “Travel Allowance” is hereby revised as stated above. This allowance may be revisited by the Compensation Committee as determined necessary.

If you have any questions as to these terms, please don’t hesitate to reach out. Please sign below to indicate your acceptance of these changes to your offer letter and return a copy to me.

Sincerely,

/s/ Traci Mazakas-Corp

Traci Mazakas-Corp

VP, Total Rewards & Workforce Enablement

Agreed and accepted:

/s/ Stephen McMillan                        April 29, 2022
________________________________________        _______________
Steve McMillan                            Date

EX-31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO SECURITIES

EXCHANGE ACT RULE 13a-14

I, Stephen McMillan, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Teradata Corporation;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date : May 6, 2022	/s/ Stephen McMillan
	Stephen McMillan
	President and Chief Executive Officer

EX-31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO SECURITIES

EXCHANGE ACT RULE 13a-14

I, Claire Bramley, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Teradata Corporation;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date : May 6, 2022	/s/ Claire Bramley
	Claire Bramley
	Chief Financial Officer

EX-32

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Teradata Corporation, a Delaware corporation (the “Company”), on Form 10-Q for the period ended March 31, 2022 as filed with the U.S. Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned officers of the Company does hereby certify, pursuant to 18 U.S.C. § 1350 (section 906 of the Sarbanes-Oxley Act of 2002), that:

(1)    the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)    the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

The foregoing certification (i) is given to such officers’ knowledge, based upon such officers’ investigation as such officers reasonably deem appropriate; and (ii) is being furnished solely pursuant to 18 U.S.C. § 1350 (section 906 of the Sarbanes-Oxley Act of 2002) and is not being filed as part of the Report or as a separate disclosure document.

Date: May 6 2022	/s/ Stephen McMillan
	Stephen McMillan
	President and Chief Executive Officer
Date: May 6, 2022	/s/ Claire Bramley
	Claire Bramley
	Chief Financial Officer

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signatures that appear in typed form within the electronic version of this written statement required by Section 906, has been provided to Teradata Corporation and will be retained by Teradata Corporation and furnished to the United States Securities and Exchange Commission or its staff upon request.

XML

Cover - shares shares in Millions	3 Months Ended
	Mar. 31, 2022	Apr. 29, 2022
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2022
Document Transition Report	false
Entity File Number	001-33458
Entity Registrant Name	TERADATA CORPORATION
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	75-3236470
Entity Address, Address Line One	17095 Via Del Campo
Entity Address, City or Town	San Diego
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	92127
City Area Code	866
Local Phone Number	548-8348
Title of 12(b) Security	Common Stock, $0.01 par value
Trading Symbol	TDC
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		104.7
Amendment Flag	false
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q1
Entity Central Index Key	0000816761
Current Fiscal Year End Date	--12-31

XML

Condensed Consolidated Statements of Income (Unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Revenue
Revenue	$ 496	$ 491
Cost of revenue
Cost of revenue	195	184
Gross profit	301	307
Operating expenses
Selling, general and administrative expenses	157	149
Research and development expenses	76	77
Total operating expenses	233	226
Income from operations	68	81
Other expense, net
Interest expense	(6)	(7)
Interest income	2	1
Other expense	(9)	(3)
Total other expense, net	(13)	(9)
Income before income taxes	55	72
Income tax expense	19	19
Net income	$ 36	$ 53
Net income per common share
Basic (in dollars per share)	$ 0.34	$ 0.49
Diluted (in dollars per share)	$ 0.33	$ 0.47
Weighted average common shares outstanding
Basic (in shares)	105.0	108.7
Diluted (in shares)	108.6	112.8
Total recurring
Revenue
Revenue	$ 386	$ 372
Cost of revenue
Cost of revenue	105	90
Subscription software licenses
Revenue
Revenue	93	93
Cost of revenue
Cost of revenue	7	4
Services and other
Revenue
Revenue	293	279
Cost of revenue
Cost of revenue	98	86
Perpetual software licenses, hardware and other
Revenue
Revenue	26	23
Cost of revenue
Cost of revenue	18	11
Consulting services
Revenue
Revenue	84	96
Cost of revenue
Cost of revenue	$ 72	$ 83

XML

Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Statement of Comprehensive Income [Abstract]
Net income	$ 36	$ 53
Other comprehensive income (loss):
Foreign currency translation adjustments	(1)	(8)
Derivatives:
Unrealized gain on derivatives, before tax	8	4
Unrealized gain on derivatives, tax portion	(2)	(1)
Unrealized gain on derivatives, net of tax	6	3
Defined benefit plans:
Defined benefit plan adjustment, before tax	3	2
Defined benefit plan adjustment, tax portion	(1)	0
Defined benefit plan adjustment, net of tax	2	2
Other comprehensive income (loss)	7	(3)
Comprehensive income	$ 43	$ 50

XML

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Millions	Mar. 31, 2022	Dec. 31, 2021
Current assets
Cash and cash equivalents	$ 404	$ 592
Accounts receivable, net	330	336
Inventories	16	26
Other current assets	113	152
Total current assets	863	1,106
Property and equipment, net	274	288
Right of use assets - operating lease, net	22	26
Goodwill	395	396
Capitalized contract costs, net	109	111
Deferred income taxes	200	202
Other assets	32	40
Total assets	1,895	2,169
Current liabilities
Current portion of long-term debt	75	88
Current portion of finance lease liability	76	77
Current portion of operating lease liability	11	12
Accounts payable	78	67
Payroll and benefits liabilities	91	148
Deferred revenue	580	552
Other current liabilities	82	89
Total current liabilities	993	1,033
Long-term debt	324	324
Finance lease liability	56	53
Operating lease liability	15	18
Pension and other postemployment plan liabilities	133	138
Long-term deferred revenue	19	27
Deferred tax liabilities	16	7
Other liabilities	102	109
Total liabilities	1,658	1,709
Commitments and contingencies (Note 8)
Stockholders’ equity
Preferred stock: par value $0.01 per share, 100.0 shares authorized, no shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively	0	0
Common stock: par value $0.01 per share, 500.0 shares authorized, 104.7 and 107.2 shares issued at March 31, 2022 and December 31, 2021, respectively	1	1
Paid-in capital	1,792	1,808
Accumulated deficit	(1,425)	(1,211)
Accumulated other comprehensive loss	(131)	(138)
Total stockholders’ equity	237	460
Total liabilities and stockholders’ equity	$ 1,895	$ 2,169

XML

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Mar. 31, 2022	Dec. 31, 2021
Statement of Financial Position [Abstract]
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized (in shares)	100,000,000.0	100,000,000.0
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	500,000,000.0	500,000,000.0
Common stock, shares issued (in shares)	104,700,000	107,200,000

XML

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Operating activities
Net income	$ 36	$ 53
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	40	39
Stock-based compensation expense	31	21
Deferred income taxes	8	10
Changes in assets and liabilities:
Receivables	6	(36)
Inventories	10	13
Current payables and accrued expenses	(49)	(44)
Deferred revenue	20	63
Other assets and liabilities	49	(9)
Net cash provided by operating activities	151	110
Investing activities
Expenditures for property and equipment	(1)	(4)
Additions to capitalized software	0	(1)
Net cash used in investing activities	(1)	(5)
Financing activities
Repurchases of common stock	(300)	(83)
Repayments of long-term borrowings	(13)	(6)
Payments of finance leases	(22)	(15)
Other financing activities, net	4	13
Net cash used in financing activities	(331)	(91)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(6)	(5)
(Decrease) increase in cash, cash equivalents and restricted cash	(187)	9
Cash, cash equivalents and restricted cash at beginning of period	595	533
Cash, cash equivalents and restricted cash at end of period	408	542
Supplemental cash flow disclosure:
Assets acquired under operating lease	1	2
Assets acquired under finance lease	24	45
Annual variable incentive payout settled in equity	0	17
Reconciliation of cash, cash equivalents and restricted cash to the Condensed Consolidated Balance Sheets:
Cash and cash equivalents	404
Restricted cash	4
Total cash, cash equivalents and restricted cash	$ 408	$ 542

XML

Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($) shares in Millions, $ in Millions	Total	Common Stock	Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss
Shares issued, beginning balance (in shares) at Dec. 31, 2020		108
Stockholders’ equity, beginning balance at Dec. 31, 2020	$ 400	$ 1	$ 1,656	$ (1,114)	$ (143)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	53			53
Employee stock compensation, employee stock purchase programs and option exercises, net of tax (in shares)		4
Employee stock compensation, employee stock purchase programs and option exercises, net of tax	52		52
Repurchases of common stock, retired (in shares)		(3)
Repurchases of common stock, retired	(85)			(85)
Pension and postemployment benefit plans, net of tax	2				2
Unrealized gain on derivatives, net of tax	3				3
Currency translation adjustment	(8)				(8)
Shares issued, ending balance (in shares) at Mar. 31, 2021		109
Stockholders’ equity, ending balance at Mar. 31, 2021	417	$ 1	1,708	(1,146)	(146)
Shares issued, beginning balance (in shares) at Dec. 31, 2021		107
Stockholders’ equity, beginning balance at Dec. 31, 2021	460	$ 1	1,808	(1,211)	(138)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	36			36
Employee stock compensation, employee stock purchase programs and option exercises, net of tax (in shares)		3
Employee stock compensation, employee stock purchase programs and option exercises, net of tax	34		34
Repurchase of common stock, not yet settled	(50)		(50)
Repurchases of common stock, retired (in shares)		(5)
Repurchases of common stock, retired	(250)			(250)
Pension and postemployment benefit plans, net of tax	2				2
Unrealized gain on derivatives, net of tax	6				6
Currency translation adjustment	(1)				(1)
Shares issued, ending balance (in shares) at Mar. 31, 2022		105
Stockholders’ equity, ending balance at Mar. 31, 2022	$ 237	$ 1	$ 1,792	$ (1,425)	$ (131)

XML

Basis of Presentation	3 Months Ended
	Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of PresentationThese statements have been prepared pursuant to the rules and regulations of the United States Securities and Exchange Commission ("SEC") and, in accordance with those rules and regulations, do not include all information and footnote disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP"). In the opinion of management, the condensed consolidated financial statements reflect all adjustments, consisting only of normal recurring adjustments, necessary to fairly state the results of operations, financial position and cash flows of Teradata Corporation ("Teradata" or the "Company") for the interim periods presented herein. The year-end 2021 condensed consolidated balance sheet data was derived from audited financial statements but does not include all disclosures required by GAAP. The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make use of estimates and assumptions that affect the reported amounts and disclosures. Actual results may vary from these estimates. These condensed consolidated interim financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in Teradata’s most recent Annual Report on Form 10-K for the fiscal year ended December 31, 2021 (the "2021 Annual Report"). The results of operations for any interim period are not necessarily indicative of the results of operations to be expected for the full year.

XML

New Accounting Pronouncements

3 Months Ended

Mar. 31, 2022

Accounting Standards Update and Change in Accounting Principle [Abstract]

New Accounting Pronouncements

New Accounting Pronouncements

Reference Rate Reform. In March 2020, the Financial Accounting Standards Board ("FASB") issued new guidance to provide relief to companies that will be impacted by the expected change in benchmark interest rates, as participating banks will no longer be required to submit London Interbank Offered Rate ("LIBOR") quotes by the U.K. Financial Conduct Authority. The new guidance allows companies to, provided the only change to existing contracts are a change to an approved benchmark interest rate, account for modifications as a continuance of the existing contract without additional analysis. For new and existing contracts, companies may elect to apply the amendments as of March 12, 2020 through December 31, 2022. The Company is currently evaluating this new guidance to determine the impact it may have on its condensed consolidated financial statements or related disclosures.

Recently Adopted Guidance

In August 2020, the FASB issued Accounting Standard Update ("ASU") 2020-06, an update to Accounting Standard Codification ("ASC") Topic 470, Subtopic - 20, Debt - Debt with Conversion and Other Options, and ASC Topic 815, Subtopic - 4, Derivatives and Hedging - Contracts in Entity's Own Equity. ASU 2020-06 simplifies the guidance for certain financial instruments with characteristics of liability and equity, including convertible instruments and contracts on an entity’s own equity by reducing the number of accounting models for convertible instruments and amends guidance in ASC Topic 260, Earnings Per Share, relating to the computation of earnings per share for convertible instruments and contracts on an entity’s own equity. The Company adopted the provisions of ASU 2020-06 on January 1, 2022. The adoption of this standard did not have an impact on the Company's condensed consolidated financial statements.

XML

Revenue from Contracts with Customers

3 Months Ended

Mar. 31, 2022

Revenue from Contract with Customer [Abstract]

Revenue from Contracts with Customers

Revenue from Contracts with Customers

Disaggregation of Revenue from Contracts with Customers

The following table presents a disaggregation of revenue:

	Three Months Ended March 31,
in millions	2022		2021
Americas
Recurring	$	246	$	218
Perpetual software licenses, hardware and other	12		7
Consulting services	32		38
Total Americas	290		263
EMEA
Recurring	89		101
Perpetual software licenses, hardware and other	11		13
Consulting services	29		33
Total EMEA	129		147
APJ
Recurring	51		53
Perpetual software licenses, hardware and other	3		3
Consulting services	23		25
Total APJ	77		81
Total Revenue	$	496	$	491

Rental revenue, which is included in recurring revenue in the above table, was as follows:

	Three Months Ended March 31,
in millions	2022		2021
Rental revenue*	$	50	$	39

*Rental revenue includes hardware maintenance.

Contract Balances

The timing of revenue recognition, billings and cash collections results in billed accounts receivable, contract assets, and customer advances and deposits (deferred revenue or contract liabilities) on the condensed consolidated balance sheet. Accounts receivable include amounts due from customers that are unconditional. Contract assets relate to the Company’s rights to consideration for goods delivered or services completed and recognized as revenue but billing and the right to receive payment is conditional upon the completion of other performance obligations. Contract assets are included in other current assets on the balance sheet and are transferred to accounts receivable when the rights become unconditional. Deferred revenue consists of advance payments and billings in excess of revenue recognized. Deferred revenue is classified as either current or noncurrent based on the timing of when the Company expects to recognize revenue. These assets and liabilities are reported on a contract-by-contract basis at the end of each reporting period.

The following table provides information about receivables, contract assets and deferred revenue from contracts with customers:

	As of
in millions	March 31, 2022	December 31, 2021
Accounts receivable, net	330	$	336
Contract assets	17	10
Current deferred revenue	580	552
Long-term deferred revenue	19	27

Revenue recognized during the three months ended March 31, 2022 from amounts included in deferred revenue at the beginning of the period was $135 million.

Transaction Price Allocated to Unsatisfied Obligations

The following table includes estimated revenue expected to be recognized in the future related to the Company's unsatisfied (or partially satisfied) obligations at March 31, 2022:

in millions	Total at March 31, 2022		Year 1		Year 2 and Thereafter
Remaining unsatisfied obligations	$	2,281	$	1,506	$	775

The amounts above represent the price of firm orders for which work has not been performed or goods have not been delivered and exclude unexercised contract options outside the stated contractual term that do not represent material rights to the customer. Although the Company believes that the contract value in the above table is firm, approximately $1,366 million of the amount is under contracts that are subject to customer-only general cancellation for convenience terms that the Company is contractually obligated to perform unless the customer notifies us of cancellation. The Company expects to recognize revenue of approximately $446 million in the next year from contracts that are non-cancelable. The Company believes the inclusion of this information is important to understanding the obligations that the Company is contractually required to perform and provides useful information regarding remaining obligations related to these executed contracts.Contract Costs

The Company capitalizes sales commissions and other contract costs that are incremental direct costs of obtaining customer contracts if the expected amortization period of the asset is greater than one year. These costs are recorded in capitalized contract costs, net on the Company’s balance sheet. The capitalized amounts are calculated based on the annual recurring revenue and contract value for individual multi-term contracts. The judgments made in determining the amount of costs incurred include whether the commissions are in fact incremental and would not have occurred absent the customer contract. Costs to obtain a contract are amortized as selling, general and administrative expenses on a straight-line basis over the expected period of benefit, which is typically around four years. These costs are periodically reviewed for impairment. The following table identifies the activity relating to capitalized contract costs:

in millions	December 31, 2021		Capitalized		Amortization		March 31, 2022
Capitalized contract costs	$	111	$	13	$	(15)	$	109

in millions	December 31, 2020		Capitalized		Amortization		March 31, 2021
Capitalized contract costs	$	98	$	13	$	(12)	$	99

XML

Contract Costs

3 Months Ended

Mar. 31, 2022

Capitalized Contract Cost [Abstract]

Contract Costs

Revenue from Contracts with Customers

Disaggregation of Revenue from Contracts with Customers

The following table presents a disaggregation of revenue:

	Three Months Ended March 31,
in millions	2022		2021
Americas
Recurring	$	246	$	218
Perpetual software licenses, hardware and other	12		7
Consulting services	32		38
Total Americas	290		263
EMEA
Recurring	89		101
Perpetual software licenses, hardware and other	11		13
Consulting services	29		33
Total EMEA	129		147
APJ
Recurring	51		53
Perpetual software licenses, hardware and other	3		3
Consulting services	23		25
Total APJ	77		81
Total Revenue	$	496	$	491

Rental revenue, which is included in recurring revenue in the above table, was as follows:

	Three Months Ended March 31,
in millions	2022		2021
Rental revenue*	$	50	$	39

*Rental revenue includes hardware maintenance.

Contract Balances

The timing of revenue recognition, billings and cash collections results in billed accounts receivable, contract assets, and customer advances and deposits (deferred revenue or contract liabilities) on the condensed consolidated balance sheet. Accounts receivable include amounts due from customers that are unconditional. Contract assets relate to the Company’s rights to consideration for goods delivered or services completed and recognized as revenue but billing and the right to receive payment is conditional upon the completion of other performance obligations. Contract assets are included in other current assets on the balance sheet and are transferred to accounts receivable when the rights become unconditional. Deferred revenue consists of advance payments and billings in excess of revenue recognized. Deferred revenue is classified as either current or noncurrent based on the timing of when the Company expects to recognize revenue. These assets and liabilities are reported on a contract-by-contract basis at the end of each reporting period.

The following table provides information about receivables, contract assets and deferred revenue from contracts with customers:

	As of
in millions	March 31, 2022	December 31, 2021
Accounts receivable, net	330	$	336
Contract assets	17	10
Current deferred revenue	580	552
Long-term deferred revenue	19	27

Revenue recognized during the three months ended March 31, 2022 from amounts included in deferred revenue at the beginning of the period was $135 million.

Transaction Price Allocated to Unsatisfied Obligations

The following table includes estimated revenue expected to be recognized in the future related to the Company's unsatisfied (or partially satisfied) obligations at March 31, 2022:

in millions	Total at March 31, 2022		Year 1		Year 2 and Thereafter
Remaining unsatisfied obligations	$	2,281	$	1,506	$	775

The amounts above represent the price of firm orders for which work has not been performed or goods have not been delivered and exclude unexercised contract options outside the stated contractual term that do not represent material rights to the customer. Although the Company believes that the contract value in the above table is firm, approximately $1,366 million of the amount is under contracts that are subject to customer-only general cancellation for convenience terms that the Company is contractually obligated to perform unless the customer notifies us of cancellation. The Company expects to recognize revenue of approximately $446 million in the next year from contracts that are non-cancelable. The Company believes the inclusion of this information is important to understanding the obligations that the Company is contractually required to perform and provides useful information regarding remaining obligations related to these executed contracts.Contract Costs

The Company capitalizes sales commissions and other contract costs that are incremental direct costs of obtaining customer contracts if the expected amortization period of the asset is greater than one year. These costs are recorded in capitalized contract costs, net on the Company’s balance sheet. The capitalized amounts are calculated based on the annual recurring revenue and contract value for individual multi-term contracts. The judgments made in determining the amount of costs incurred include whether the commissions are in fact incremental and would not have occurred absent the customer contract. Costs to obtain a contract are amortized as selling, general and administrative expenses on a straight-line basis over the expected period of benefit, which is typically around four years. These costs are periodically reviewed for impairment. The following table identifies the activity relating to capitalized contract costs:

in millions	December 31, 2021		Capitalized		Amortization		March 31, 2022
Capitalized contract costs	$	111	$	13	$	(15)	$	109

in millions	December 31, 2020		Capitalized		Amortization		March 31, 2021
Capitalized contract costs	$	98	$	13	$	(12)	$	99

XML

Supplemental Financial Information

3 Months Ended

Mar. 31, 2022

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Supplemental Financial Information

Supplemental Financial Information

	As of
In millions	March 31, 2022		December 31, 2021
Inventories
Finished goods	$	7	$	17
Service parts	9		9
Total inventories	$	16	$	26
Deferred revenue
Deferred revenue, current	$	580	$	552
Long-term deferred revenue	19		27
Total deferred revenue	$	599	$	579

XML

Income Taxes

3 Months Ended

Mar. 31, 2022

Income Tax Disclosure [Abstract]

Income Taxes

Income Taxes

Income tax provisions for interim periods are based on estimated annual income tax rates, adjusted to reflect the effects of any significant infrequent or unusual items which are required to be discretely recognized within the current interim period. The Company expects that a majority of its foreign earnings will be repatriated back to the United States ("U.S."). As a result, the effective tax rates in the periods presented are largely based upon the forecasted pre-tax earnings mix and allocation of certain expenses in various taxing jurisdictions where the Company conducts its business.

The effective tax rate is as follows:

	Three Months Ended March 31,
In millions	2022		2021
Effective tax rate	34.5	%	26.4	%

For the three months ended March 31, 2022, the Company recorded $4 million of net discrete tax benefits, a majority of which related to the excess tax benefit derived from stock compensation vesting. In addition, the Company’s effective tax rate increased by 9% as a result of an increase in the Company’s forecasted global intangible low-taxed income ("GILTI") tax liability as described below.

For the three months ended March 31, 2021, the Company recorded $3 million of discrete tax benefit, a majority of which related to the excess tax benefit derived from stock compensation vesting.

The Company estimates its annual effective tax rate for 2022 to be approximately 37%, which takes into consideration, among other things, the forecasted earnings mix by jurisdiction and the impact of discrete tax items to be recognized in 2022. Under U.S. tax law, U.S. shareholders are subject to a tax on GILTI earned by certain foreign subsidiaries. The Company has elected to provide for the tax expense related to GILTI in the year in which the tax is incurred. Effective on January 1, 2022, the U.S. tax law changed and now requires R&D expenses to be capitalized and amortized for tax purposes under Internal Revenue Code Section 174; as a result of this law change, the Company is currently forecasting approximately $12 million of tax expense related to GILTI in our marginal effective tax rate for 2022. Should Congress enact proposed legislation to defer the implementation of R&D capitalization rules retroactively by the end of the year, the Company’s GILTI tax and overall effective tax rate for 2022 would be significantly reduced.

XML

Derivative Instruments and Hedging Activities

3 Months Ended

Mar. 31, 2022

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Instruments and Hedging Activities

Derivative Instruments and Hedging ActivitiesAs a portion of Teradata’s operations is conducted outside the U.S. and in currencies other than the U.S. dollar, the Company is exposed to potential gains and losses from changes in foreign currency exchange rates. In an attempt to mitigate the impact of currency fluctuations, the Company uses foreign exchange forward contracts to hedge

transactional exposures resulting predominantly from foreign currency denominated inter-company receivables and payables. The forward contracts are designated as fair value hedges of specified foreign currency denominated inter-company receivables and payables and generally mature in three months or less. The fair values of foreign exchange contracts are based on market spot and forward exchange rates and represent estimates of possible value that may not be realized in the future. Across its portfolio of contracts, Teradata has both long and short positions relative to the U.S. dollar. As a result, Teradata’s net involvement is less than the total contract notional amount of the Company’s foreign exchange forward contracts.

Gains and losses from foreign exchange forward contracts are fully recognized each period and reported along with the offsetting gain or loss of the related hedged item, either in cost of revenues, operating expenses or in other income (expense), depending on the nature of the related hedged item.

In June 2018, Teradata executed a five-year interest rate swap with a $500 million initial notional amount to hedge the floating interest rate of its term loan, as more fully described in Note 10. The Company uses interest rate swaps to manage interest rate risks on future interest payments caused by interest rate changes on its variable rate term loan. The notional amount of the hedge steps down according to the amortization schedule of the term loan. The notional amount of the hedge was $400 million as of March 31, 2022.

The Company performed an initial effectiveness assessment on the interest rate swap, and the hedge was determined to be effective. The hedge is being evaluated qualitatively on a quarterly basis for effectiveness. Changes in fair value are recorded in Accumulated Other Comprehensive Loss and periodic settlements of the swap will be recorded in interest expense along with the interest on amounts outstanding under the term loan.

The following table identifies the contract notional amount of the Company’s derivative financial instruments:

	As of
In millions	March 31, 2022		December 31, 2021
Contract notional amount of foreign exchange forward contracts	$	133	$	110
Net contract notional amount of foreign exchange forward contracts	$	14	$	41
Contract notional amount of interest rate swap	$	400	$	413

All derivatives are recognized in the condensed consolidated balance sheets at their fair value. The notional amounts represent agreed-upon amounts on which calculations of dollars to be exchanged are based and are an indication of the extent of Teradata’s involvement in such instruments. These notional amounts do not represent amounts exchanged by the parties and, therefore, are not a measure of the instruments. Refer to Note 9 for disclosures related to the fair value of all derivative assets and liabilities.

The Company does not hold or issue derivative financial instruments for trading purposes, nor does it hold or issue leveraged derivative instruments. By using derivative financial instruments to hedge exposures to changes in foreign exchange and interest rates, the Company exposes itself to credit risk. The Company manages exposure to counterparty credit risk by entering into derivative financial instruments with highly rated institutions that can be expected to fully perform under the terms of the applicable contracts.

XML

Commitments and Contingencies

3 Months Ended

Mar. 31, 2022

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Commitments and Contingencies

Legal Proceedings. In the ordinary course of business, the Company is subject to proceedings, lawsuits, governmental investigations, claims and other matters, including those that relate to the environment, health and safety, employee benefits, export compliance, intellectual property, tax matters and other regulatory compliance and general matters. It is not currently a party to any litigation, nor is it aware of any pending or threatened litigation against it that the Company believes would materially affect its business, operating results, financial condition or cash flows, other than the following.

On June 19, 2018, the Company and certain of its subsidiaries filed a lawsuit (the "TD-SAP 1" suit) in the U.S. District Court for the Northern District of California against SAP SE, SAP America, Inc., and SAP Labs, LLC (collectively, "SAP"). In the TD-SAP 1 lawsuit, the Company alleged, among other things, that SAP misappropriated certain of the Company’s trade secrets within the Company’s enterprise data analytics and warehousing products and used such trade secrets to help develop, improve, introduce, and sell one or more

competing products. The Company further alleged that SAP employed anticompetitive practices using its substantial market position in the enterprise resource planning applications market to pressure the Company’s customers and prospective customers to use one or more of SAP's competing products and reduce or eliminate customers' and prospective customers' use of the Company's offerings. The Company sought an injunction barring SAP’s alleged conduct, monetary damages, and other available legal and equitable relief. In July 2019, SAP filed patent infringement counterclaims against the Company based on five of SAP’s U.S. patents. On August 31, 2020, the Company filed a second lawsuit against SAP (the "TD-SAP 2" suit) in the U.S. District Court for the Northern District of California, in which the Company alleged infringement by SAP of four of the Company's U.S. patents. On February 16, 2021, SAP filed additional patent infringement counterclaims against the Company in response. On the same day, SAP also filed a lawsuit in Germany (the "TD-SAP 3" suit) for infringement of a single German patent. In November 2021, the district court dismissed the Company’s antitrust claims and most of its trade secret claims in the TD-SAP 1 suit. In December 2021, the Company appealed that decision to the U.S. Court of Appeals for the Federal Circuit in Washington, D.C. In the meantime, the Company and SAP have entered into a partial settlement agreement that has resulted in full dismissal of all claims and counterclaims in the TD-SAP 2 suit in California and the TD-SAP 3 suit in Germany as well as a stay of all claims and counterclaims remaining in the TD-SAP 1 suit pending resolution of the Company’s appeal. Currently, it is not possible to determine the likelihood of a loss or a reasonably estimated range of loss, if any, pertaining to any of SAP’s remaining patent counterclaims in the TD-SAP 1 lawsuit.

Other Contingencies. The Company provides its customers with certain indemnification rights. In general, the Company agrees to indemnify the customer if a third party asserts patent or other infringement on the part of the customer for its use of the Company’s offerings. The Company has indemnification obligations under its charter and bylaws to its officers and directors, and has entered into indemnification agreements with the officers and directors of its subsidiaries. From time to time, the Company also enters into agreements in connection with its acquisition and divestiture activities that include indemnification obligations by the Company. The fair value of these indemnification obligations is typically not readily determinable due to the conditional nature of the Company’s potential obligations and the specific facts and circumstances involved with each particular agreement. As such, the Company has generally not recorded a liability in connection with these indemnification arrangements. Historically, payments made by the Company under these types of agreements have not had a material effect on the Company’s consolidated financial condition, results of operations or cash flows.

Concentrations of Risk. The Company is potentially subject to concentrations of credit risk on accounts receivable and financial instruments such as hedging instruments, and cash and cash equivalents. Credit risk includes the risk of nonperformance by counterparties. The maximum potential loss may exceed the amount recognized on the balance sheet. Exposure to credit risk is managed through credit approvals, credit limits, selecting major international financial institutions (as counterparties to hedging transactions) and monitoring procedures. Teradata’s business often involves large transactions with customers, and if one or more of those customers were to default in its obligations under applicable contractual arrangements, the Company could be exposed to potentially significant losses. However, management believes that the reserves for potential losses were adequate at March 31, 2022 and December 31, 2021.

The Company is also potentially subject to concentrations of supplier risk. Our hardware components are assembled exclusively by Flex Ltd. ("Flex"). Flex procures a wide variety of components used in the manufacturing process on behalf of the Company. Although many of these components are available from multiple sources, Teradata utilizes preferred supplier relationships to provide more consistent and optimal quality, cost and delivery. Typically, these preferred suppliers maintain alternative processes and/or facilities to ensure continuity of supply. Given the Company’s strategy to outsource its manufacturing activities to Flex and to source certain components from single suppliers, a disruption in production at Flex or at a supplier could impact the timing of customer shipments and/or Teradata’s operating results. In addition, a significant change in the forecasts to any of these preferred suppliers could result in purchase obligations for components that may be in excess of demand.

XML

Fair Value Measurements

3 Months Ended

Mar. 31, 2022

Fair Value Disclosures [Abstract]

Fair Value Measurements

Fair Value Measurements

Fair value measurements are established utilizing a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. These tiers include: Level 1, defined as observable inputs such as quoted prices in active markets for identical assets or liabilities; Level 2, defined as significant other observable inputs, such as quoted prices in active markets for similar assets or liabilities, or quoted prices in less-active markets for identical assets; and Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions. Financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.

The Company’s assets and liabilities measured at fair value on a recurring basis include money market funds, interest rate swaps and foreign currency exchange contracts. A portion of the Company’s excess cash reserves are held in money market funds which generate interest income based on the prevailing market rates. Money market funds are included in cash and cash equivalents in the Company’s balance sheet. Money market fund holdings are measured at fair value using quoted market prices and are classified within Level 1 of the valuation hierarchy.

When deemed appropriate, the Company minimizes its exposure to changes in foreign currency exchange rates through the use of derivative financial instruments, specifically, foreign exchange forward contracts. Additionally, in June 2018, Teradata executed a five-year interest rate swap with a $500 million initial notional amount in order to hedge the floating interest rate on its term loan. The fair value of these contracts and swaps are measured at the end of each interim reporting period using observable inputs other than quoted prices, specifically market spot and forward exchange rates. As such, these derivative instruments are classified within Level 2 of the valuation hierarchy. Fair value of unrealized gains for open contracts are recorded in other assets and the fair value of unrealized losses are recorded in other liabilities in the Company's balance sheet. The fair value of foreign exchange forward contract assets and liabilities at March 31, 2022 and December 31, 2021 was not material. Realized gains and losses from the Company’s fair value hedges net of corresponding gains or losses on the underlying exposures were immaterial for the three months ended March 31, 2022 and 2021.

The Company’s other assets and liabilities measured at fair value on a recurring basis and subject to fair value disclosure requirements at March 31, 2022 and December 31, 2021 were as follows:

			Fair Value Measurements at Reporting Date Using
In millions	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Assets
Money market funds at March 31, 2022	$	84	$	84	$	—	$	—
Money market funds at December 31, 2021	$	148	$	148	$	—	$	—
Liabilities
Interest rate swap at March 31, 2022	$	4	$	—	$	4	$	—
Interest rate swap at December 31, 2021	$	12	$	—	$	12	$	—

XML

Debt

3 Months Ended

Mar. 31, 2022

Debt Disclosure [Abstract]

Debt

DebtIn June 2018, Teradata replaced an existing 5 year, $400 million revolving credit facility with a new $400 million revolving credit facility (the "Credit Facility"). The Credit Facility expires in June 2023, at which point any remaining outstanding borrowings would be due for repayment unless extended by agreement of the parties for up to two additional one-year periods. In addition, under the terms of the Credit Facility, Teradata from time to time and subject to certain conditions may increase the lending commitments under the Credit Facility in an aggregate principal amount up to an additional $200 million, to the extent that existing or new lenders agree to provide such additional commitments. The outstanding principal amount of the Credit Facility bears interest at a floating rate based upon, at Teradata’s option, a negotiated base rate or a Eurodollar rate plus, in each case, a margin based on Teradata’s leverage ratio. In the near term, Teradata would anticipate choosing a floating rate based on LIBOR. The

Credit Facility is unsecured but is guaranteed by certain of Teradata’s material domestic subsidiaries and contains certain representations and warranties, conditions, affirmative, negative and financial covenants, and events of default customary for such facilities. As of March 31, 2022, the Company had no borrowings outstanding under the Credit Facility, leaving $400 million in borrowing capacity available under the Credit Facility. The Company was in compliance with all covenants under the Credit Facility as of March 31, 2022.

Also, in June 2018, Teradata closed on a senior unsecured $500 million five-year term loan, the proceeds of which plus additional cash-on-hand were used to pay off the remaining $525 million of principal on its previous term loan. The term loan is payable in quarterly installments, which commenced on June 30, 2019, with 1.25% of the initial principal amount due on each of the first eight payment dates; 2.50% of the initial principal amount due on each of the next four payment dates; 5.0% of the initial principal amount due on each of the next three payment dates; and all remaining principal due in June 2023. The outstanding principal amount of the term loan bears interest at a floating rate based upon a negotiated base rate or a Eurodollar rate, plus in each case, a margin based on the leverage ratio of the Company. As of March 31, 2022, the term loan principal outstanding was $400 million. As disclosed in Note 7, Teradata entered into an interest rate swap to hedge the floating interest rate of the term loan. As a result of the swap, Teradata’s fixed rate on the term loan equals 2.86% plus the applicable leverage-based margin as defined in the term loan agreement. As of March 31, 2022, the all-in fixed rate is 4.23%. The Company was in compliance with all covenants under the term loan as of March 31, 2022.

Teradata’s term loan is recognized on the Company’s balance sheet at its unpaid principal balance, net of deferred issuance costs, and is not subject to fair value measurement. However, given that the loan carries a variable rate, the Company estimates that the unpaid principal balance of the term loan would approximate its fair value. If measured at fair value in the financial statements, the Company’s term loan would be classified as Level 2 in the fair value hierarchy.

XML

Earnings per Share

3 Months Ended

Mar. 31, 2022

Earnings Per Share [Abstract]

Earnings per Share

Earnings per Share

Basic earnings per share is calculated by dividing net income by the weighted average number of shares outstanding during the reported period. The calculation of diluted earnings per share is similar to basic earnings per share, except that the weighted average number of shares outstanding includes the dilution from potential shares resulting from stock options, restricted stock awards and other stock awards. The components of basic and diluted earnings per share are as follows:

	Three Months Ended March 31,
In millions, except per share amounts	2022		2021
Net income attributable to common stockholders	$	36	$	53
Weighted average outstanding shares of common stock	105.0		108.7
Dilutive effect of employee stock options, restricted stock and other stock awards	3.6		4.1
Common stock and common stock equivalents	108.6		112.8
Net income per share:
Basic	$	0.34	$	0.49
Diluted	$	0.33	$	0.47

Options to purchase 0.1 million shares of common stock for the three months ended March 31, 2022 and 1.2 million shares of common stock for the three months ended March 31, 2021 were not included in the computation of diluted earnings per share because the exercise prices of these options were greater than the average market price of the common shares for the period, and therefore would have been anti-dilutive.

Accelerated Share Repurchase Agreement ("ASR")

On February 9, 2022 Teradata entered into an ASR agreement with JPMorgan Chase Bank, National Association ("JPMorgan Chase") to purchase shares of its common stock from JPMorgan Chase for an aggregate purchase price of $250 million. Pursuant to the ASR, the Company received an initial delivery of 3,930,045 shares of common stock based on the $50.89 closing price of the common stock on February 8, 2022. As a result, approximately $50 million remains at JPMorgan Chase for additional repurchases until the completion of the ASR. The ASR

agreement was entered into pursuant to the Company's open market share repurchase authorization as discussed in the Financial Condition, Liquidity and Capital Resources section of Item 2 in this Quarterly Report on Form 10-Q. The final number of shares that will be delivered to Teradata under the ASR will be based on the average of the daily volume-weighted average trading prices of Teradata’s common stock during the term of the ASR, less a discount. The Company expects to receive the remaining shares no later than August 9, 2022. The effect of the potential share settlement is excluded in the diluted EPS calculation as the effect is anti-dilutive.

XML

Segment and Other Supplemental Information

3 Months Ended

Mar. 31, 2022

Segment Reporting [Abstract]

Segment and Other Supplemental Information

Segment and Other Supplemental Information

Teradata manages its business under three geographic regions, which are also the Company’s operating segments: (1) Americas region (North America and Latin America); (2) EMEA region (Europe, Middle East and Africa) and (3) APJ region (Asia Pacific and Japan). For purposes of discussing results by segment, management excludes the impact of certain items, consistent with the manner by which management evaluates the performance of each segment. This format is useful to investors because it allows analysis and comparability of operating trends. It also includes the same information that is used by Teradata management to make decisions regarding the segments and to assess financial performance. The chief operating decision maker, who is the Company's President and Chief Executive Officer, evaluates the performance of the segments based on revenue and multiple profit measures, including segment gross profit. For management reporting purposes, assets are not allocated to the segments.

The following table presents segment revenue and segment gross profit for the Company:

	Three Months Ended March 31,
In millions	2022		2021
Segment revenue
Americas	$	290	$	263
EMEA	129		147
APJ	77		81
Total revenue	496		491
Segment gross profit
Americas	189		182
EMEA	78		88
APJ	45		45
Total segment gross profit	312		315
Stock-based compensation costs	5		3
Acquisition, integration, reorganization and transformation-related costs	6		5
Total gross profit	301		307
Selling, general and administrative expenses	157		149
Research and development expenses	76		77
Income from operations	$	68	$	81

XML

New Accounting Pronouncements (Policies)

3 Months Ended

Mar. 31, 2022

Accounting Standards Update and Change in Accounting Principle [Abstract]

New Accounting Pronouncements

New Accounting Pronouncements

Reference Rate Reform. In March 2020, the Financial Accounting Standards Board ("FASB") issued new guidance to provide relief to companies that will be impacted by the expected change in benchmark interest rates, as participating banks will no longer be required to submit London Interbank Offered Rate ("LIBOR") quotes by the U.K. Financial Conduct Authority. The new guidance allows companies to, provided the only change to existing contracts are a change to an approved benchmark interest rate, account for modifications as a continuance of the existing contract without additional analysis. For new and existing contracts, companies may elect to apply the amendments as of March 12, 2020 through December 31, 2022. The Company is currently evaluating this new guidance to determine the impact it may have on its condensed consolidated financial statements or related disclosures.

Recently Adopted Guidance

In August 2020, the FASB issued Accounting Standard Update ("ASU") 2020-06, an update to Accounting Standard Codification ("ASC") Topic 470, Subtopic - 20, Debt - Debt with Conversion and Other Options, and ASC Topic 815, Subtopic - 4, Derivatives and Hedging - Contracts in Entity's Own Equity. ASU 2020-06 simplifies the guidance for certain financial instruments with characteristics of liability and equity, including convertible instruments and contracts on an entity’s own equity by reducing the number of accounting models for convertible instruments and amends guidance in ASC Topic 260, Earnings Per Share, relating to the computation of earnings per share for convertible instruments and contracts on an entity’s own equity. The Company adopted the provisions of ASU 2020-06 on January 1, 2022. The adoption of this standard did not have an impact on the Company's condensed consolidated financial statements.

Revenue from Contract with Customer

Contract CostsThe Company capitalizes sales commissions and other contract costs that are incremental direct costs of obtaining customer contracts if the expected amortization period of the asset is greater than one year. These costs are recorded in capitalized contract costs, net on the Company’s balance sheet. The capitalized amounts are calculated based on the annual recurring revenue and contract value for individual multi-term contracts. The judgments made in determining the amount of costs incurred include whether the commissions are in fact incremental and would not have occurred absent the customer contract. Costs to obtain a contract are amortized as selling, general and administrative expenses on a straight-line basis over the expected period of benefit, which is typically around four years. These costs are periodically reviewed for impairment.

Fair Value Measurement

Fair Value MeasurementsFair value measurements are established utilizing a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. These tiers include: Level 1, defined as observable inputs such as quoted prices in active markets for identical assets or liabilities; Level 2, defined as significant other observable inputs, such as quoted prices in active markets for similar assets or liabilities, or quoted prices in less-active markets for identical assets; and Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions. Financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.The Company’s assets and liabilities measured at fair value on a recurring basis include money market funds, interest rate swaps and foreign currency exchange contracts. A portion of the Company’s excess cash reserves are held in money market funds which generate interest income based on the prevailing market rates. Money market funds are included in cash and cash equivalents in the Company’s balance sheet. Money market fund holdings are measured at fair value using quoted market prices and are classified within Level 1 of the valuation hierarchy.

XML

Revenue from Contracts with Customers (Tables)

3 Months Ended

Mar. 31, 2022

Revenue from Contract with Customer [Abstract]

Schedule of Disaggregation of Revenue

The following table presents a disaggregation of revenue:

	Three Months Ended March 31,
in millions	2022		2021
Americas
Recurring	$	246	$	218
Perpetual software licenses, hardware and other	12		7
Consulting services	32		38
Total Americas	290		263
EMEA
Recurring	89		101
Perpetual software licenses, hardware and other	11		13
Consulting services	29		33
Total EMEA	129		147
APJ
Recurring	51		53
Perpetual software licenses, hardware and other	3		3
Consulting services	23		25
Total APJ	77		81
Total Revenue	$	496	$	491

Schedule of Rental Revenue

Rental revenue, which is included in recurring revenue in the above table, was as follows:

	Three Months Ended March 31,
in millions	2022		2021
Rental revenue*	$	50	$	39

*Rental revenue includes hardware maintenance.

Schedule of Assets and Liabilities Related to Contracts with Customers

The following table provides information about receivables, contract assets and deferred revenue from contracts with customers:

	As of
in millions	March 31, 2022	December 31, 2021
Accounts receivable, net	330	$	336
Contract assets	17	10
Current deferred revenue	580	552
Long-term deferred revenue	19	27

Schedule of Estimated Revenue Expected to be Recognized in the Future

The following table includes estimated revenue expected to be recognized in the future related to the Company's unsatisfied (or partially satisfied) obligations at March 31, 2022:

in millions	Total at March 31, 2022		Year 1		Year 2 and Thereafter
Remaining unsatisfied obligations	$	2,281	$	1,506	$	775

XML

Contract Costs (Tables)

3 Months Ended

Mar. 31, 2022

Capitalized Contract Cost [Abstract]

Schedule of Activity Related to Capitalized Contract Cost

The following table identifies the activity relating to capitalized contract costs:

in millions	December 31, 2021		Capitalized		Amortization		March 31, 2022
Capitalized contract costs	$	111	$	13	$	(15)	$	109

in millions	December 31, 2020		Capitalized		Amortization		March 31, 2021
Capitalized contract costs	$	98	$	13	$	(12)	$	99

XML

Supplemental Financial Information (Tables)

3 Months Ended

Mar. 31, 2022

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Supplemental Financial Information

	As of
In millions	March 31, 2022		December 31, 2021
Inventories
Finished goods	$	7	$	17
Service parts	9		9
Total inventories	$	16	$	26
Deferred revenue
Deferred revenue, current	$	580	$	552
Long-term deferred revenue	19		27
Total deferred revenue	$	599	$	579

XML

Income Taxes (Tables)

3 Months Ended

Mar. 31, 2022

Income Tax Disclosure [Abstract]

Schedule of Effective Tax Rate

The effective tax rate is as follows:

	Three Months Ended March 31,
In millions	2022		2021
Effective tax rate	34.5	%	26.4	%

XML

Derivative Instruments and Hedging Activities (Tables)

3 Months Ended

Mar. 31, 2022

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Derivative Financial Instruments

The following table identifies the contract notional amount of the Company’s derivative financial instruments:

	As of
In millions	March 31, 2022		December 31, 2021
Contract notional amount of foreign exchange forward contracts	$	133	$	110
Net contract notional amount of foreign exchange forward contracts	$	14	$	41
Contract notional amount of interest rate swap	$	400	$	413

XML

Fair Value Measurements (Tables)

3 Months Ended

Mar. 31, 2022

Fair Value Disclosures [Abstract]

Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis and Subject to Fair Value Disclosure Requirements

The Company’s other assets and liabilities measured at fair value on a recurring basis and subject to fair value disclosure requirements at March 31, 2022 and December 31, 2021 were as follows:

			Fair Value Measurements at Reporting Date Using
In millions	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Assets
Money market funds at March 31, 2022	$	84	$	84	$	—	$	—
Money market funds at December 31, 2021	$	148	$	148	$	—	$	—
Liabilities
Interest rate swap at March 31, 2022	$	4	$	—	$	4	$	—
Interest rate swap at December 31, 2021	$	12	$	—	$	12	$	—

XML

Earnings per Share (Tables)

3 Months Ended

Mar. 31, 2022

Earnings Per Share [Abstract]

Components of Basic and Diluted Earnings Per Share

The components of basic and diluted earnings per share are as follows:

	Three Months Ended March 31,
In millions, except per share amounts	2022		2021
Net income attributable to common stockholders	$	36	$	53
Weighted average outstanding shares of common stock	105.0		108.7
Dilutive effect of employee stock options, restricted stock and other stock awards	3.6		4.1
Common stock and common stock equivalents	108.6		112.8
Net income per share:
Basic	$	0.34	$	0.49
Diluted	$	0.33	$	0.47

XML

Segment and Other Supplemental Information (Tables)

3 Months Ended

Mar. 31, 2022

Segment Reporting [Abstract]

Regional Segment Revenue and Gross Margin

The following table presents segment revenue and segment gross profit for the Company:

	Three Months Ended March 31,
In millions	2022		2021
Segment revenue
Americas	$	290	$	263
EMEA	129		147
APJ	77		81
Total revenue	496		491
Segment gross profit
Americas	189		182
EMEA	78		88
APJ	45		45
Total segment gross profit	312		315
Stock-based compensation costs	5		3
Acquisition, integration, reorganization and transformation-related costs	6		5
Total gross profit	301		307
Selling, general and administrative expenses	157		149
Research and development expenses	76		77
Income from operations	$	68	$	81

XML

Revenue from Contracts with Customers - Disaggregation of Revenue from Contracts with Customers (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Disaggregation of Revenue [Line Items]
Revenue	$ 496	$ 491
Americas
Disaggregation of Revenue [Line Items]
Revenue	290	263
EMEA
Disaggregation of Revenue [Line Items]
Revenue	129	147
APJ
Disaggregation of Revenue [Line Items]
Revenue	77	81
Recurring
Disaggregation of Revenue [Line Items]
Revenue	386	372
Recurring | Americas
Disaggregation of Revenue [Line Items]
Revenue	246	218
Recurring | EMEA
Disaggregation of Revenue [Line Items]
Revenue	89	101
Recurring | APJ
Disaggregation of Revenue [Line Items]
Revenue	51	53
Perpetual software licenses, hardware and other
Disaggregation of Revenue [Line Items]
Revenue	26	23
Perpetual software licenses, hardware and other | Americas
Disaggregation of Revenue [Line Items]
Revenue	12	7
Perpetual software licenses, hardware and other | EMEA
Disaggregation of Revenue [Line Items]
Revenue	11	13
Perpetual software licenses, hardware and other | APJ
Disaggregation of Revenue [Line Items]
Revenue	3	3
Consulting services
Disaggregation of Revenue [Line Items]
Revenue	84	96
Consulting services | Americas
Disaggregation of Revenue [Line Items]
Revenue	32	38
Consulting services | EMEA
Disaggregation of Revenue [Line Items]
Revenue	29	33
Consulting services | APJ
Disaggregation of Revenue [Line Items]
Revenue	$ 23	$ 25

XML

Revenue from Contracts with Customers - Schedule of Operating Lease Income (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Revenue from Contract with Customer [Abstract]
Rental revenue	$ 50	$ 39

XML

Revenue from Contracts with Customers - Contract Balances (Details) - USD ($) $ in Millions	Mar. 31, 2022	Dec. 31, 2021
Revenue from Contract with Customer [Abstract]
Accounts receivable, net	$ 330	$ 336
Contract assets	17	10
Current deferred revenue	580	552
Long-term deferred revenue	$ 19	$ 27

XML

Revenue from Contracts with Customers - Narrative (Details) $ in Millions	3 Months Ended
	Mar. 31, 2022 USD ($)
Revenue from Contract with Customer [Abstract]
Deferred revenue, revenue recognized	$ 135
Remaining performance obligation, amount of customer only general cancellation	1,366
Remaining performance obligation, amount of non-cancelable contracts	$ 446

XML

Revenue from Contracts with Customers - Transaction Price Allocated to the Remaining Performance Obligations (Details) $ in Millions	Mar. 31, 2022 USD ($)
Revenue from Contract with Customer [Abstract]
Revenue, remaining performance obligation	$ 2,281
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-04-01
Revenue from Contract with Customer [Abstract]
Revenue, remaining performance obligation	$ 1,506
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-04-01
Revenue from Contract with Customer [Abstract]
Revenue, remaining performance obligation	$ 775
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, period

XML

Contract Costs - Narrative (Details)	Mar. 31, 2022
Capitalized Contract Cost [Abstract]
Capitalized contract cost, amortization period	4 years

XML

Contract Costs - Schedule of Activity Related to Capitalized Contract Cost (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Capitalized Contract Cost, Net [Roll Forward]
Capitalized contract cost, net at period start	$ 111	$ 98
Capitalized	13	13
Amortization	(15)	(12)
Capitalized contract cost, net at period end	$ 109	$ 99

XML

Supplemental Financial Information (Detail) - USD ($) $ in Millions	Mar. 31, 2022	Dec. 31, 2021
Inventories
Finished goods	$ 7	$ 17
Service parts	9	9
Total inventories	16	26
Deferred revenue
Current deferred revenue	580	552
Long-term deferred revenue	19	27
Total deferred revenue	$ 599	$ 579

XML

Income Taxes - Schedule of Effective Tax Rate (Detail)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Income Tax Disclosure [Abstract]
Effective tax rate (percentage)	34.50%	26.40%

XML

Income Taxes - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2022
Operating Loss Carryforwards [Line Items]
Net discrete tax benefits	$ 4
Effective income tax rate reconciliation, GILTI percent	9.00%
Discrete income tax expense (benefit)		$ (3)
Effective tax rate (percentage)	34.50%	26.40%
Scenario, Forecast
Operating Loss Carryforwards [Line Items]
Effective tax rate (percentage)			37.00%
Effective income tax rate reconciliation, GILTI amount			$ 12

XML

Derivative Instruments and Hedging Activities - Narrative (Detail) - Interest Rate Swap - USD ($) $ in Millions	1 Months Ended
	Jun. 30, 2018	Mar. 31, 2022	Dec. 31, 2021
Derivative
Derivative, term of contract	5 years
Contract notional amount of interest rate swap	$ 500	$ 400	$ 413

XML

Derivative Instruments and Hedging Activities - Schedule of Derivative Financial Instruments (Details) - USD ($) $ in Millions	Mar. 31, 2022	Dec. 31, 2021	Jun. 30, 2018
Foreign Exchange Contract
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Contract notional amount of foreign exchange forward contracts	$ 133	$ 110
Net contract notional amount of foreign exchange forward contracts	14	41
Contract notional amount of interest rate swap	133	110
Interest Rate Swap
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Contract notional amount of foreign exchange forward contracts	400	413	$ 500
Contract notional amount of interest rate swap	$ 400	$ 413	$ 500

XML

Commitment and Contingencies (Details) - patent		1 Months Ended
	Aug. 31, 2021	Jul. 31, 2019
Commitments and Contingencies Disclosure [Abstract]
Loss contingency on patents allegedly infringed upon (in patents)		5
Gain contingency on patents allegedly infringed upon (in patents)	4

XML

Fair Value Measurements - Additional Information (Details) - Interest Rate Swap - USD ($) $ in Millions	1 Months Ended
	Jun. 30, 2018	Mar. 31, 2022	Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative, term of contract	5 years
Contract notional amount of interest rate swap	$ 500	$ 400	$ 413

XML

Fair Value Measurements - Assets and Liabilities Measured on a Recurring Basis (Details) - USD ($) $ in Millions	Mar. 31, 2022	Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Money market funds	$ 84	$ 148
Quoted Prices in Active Markets for Identical Assets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Money market funds	84	148
Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Money market funds	0	0
Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Money market funds	0	0
Interest Rate Swap
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest rate swap	4	12
Interest Rate Swap | Quoted Prices in Active Markets for Identical Assets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest rate swap	0	0
Interest Rate Swap | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest rate swap	4	12
Interest Rate Swap | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest rate swap	$ 0	$ 0

XML

Debt - Additional Information (Detail)	1 Months Ended
	Jun. 30, 2018 USD ($) renewal	Mar. 31, 2022 USD ($)
Term Loan
Debt Instrument
Extinguishment of debt, amount	$ 525,000,000
Revolving Credit Facility Ending in March 2020 | Revolving Credit Facility
Debt Instrument
Term of loan (years)	5 years
Credit facility maximum borrowing capacity	$ 400,000,000
Credit facility, additional borrowings capacity	200,000,000
Revolving Credit Facility Ending In June 2023 | Revolving Credit Facility
Debt Instrument
Credit facility maximum borrowing capacity	$ 400,000,000	$ 400,000,000
Number of renewals | renewal	2
Renewal term	1 year
Borrowings outstanding under the credit facility		0
Senior Unsecured Term Loan Issued June 2018 | Senior Unsecured Term Loan
Debt Instrument
Term of loan (years)	5 years
Debt instrument, face amount	$ 500,000,000
Principal outstanding		$ 400,000,000
Debt Instrument, Redemption, Period One
Debt Instrument
Term loan, payable quarterly installments (percentage)	1.25%
Debt Instrument, Redemption, Period Two
Debt Instrument
Term loan, payable quarterly installments (percentage)	2.50%
Debt Instrument, Redemption, Period Three
Debt Instrument
Term loan, payable quarterly installments (percentage)	5.00%
Interest Rate Swap
Debt Instrument
Fixed rate on term loan (percentage)		2.86%
All-in fixed rate (percentage)		4.23%

XML

Earnings per Share - Components of Basic and Diluted Earnings Per Share (Detail) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Earnings Per Share [Abstract]
Net income attributable to common stockholders	$ 36	$ 53
Weighted average outstanding shares of common stock (in shares)	105.0	108.7
Dilutive effect of employee stock options, restricted stock and other stock awards (in shares)	3.6	4.1
Common stock and common stock equivalents (in shares)	108.6	112.8
Net income per share:
Basic (in dollars per share)	$ 0.34	$ 0.49
Diluted (in dollars per share)	$ 0.33	$ 0.47

XML

Earnings Per Share - Additional Information (Details) - USD ($) $ / shares in Units, $ in Millions		3 Months Ended
	Feb. 08, 2022	Mar. 31, 2022	Mar. 31, 2021	Feb. 09, 2022
Earnings Per Share [Abstract]
Antidilutive options to purchase that were not included in the computation of diluted earnings per share (in shares)		100,000	1,200,000
JPMorgan Chase Accelerated Shares Repurchase Agreement
Accelerated Share Repurchases [Line Items]
Stock repurchase program, authorized amount				$ 250
Amount of shares purchased (in shares)	3,930,045
Common stock closing price (in dollars per share)	$ 50.89
Remaining authorized repurchase amount				$ 50

XML

Segment and Other Supplemental Information - Additional Information (Detail)	3 Months Ended
	Mar. 31, 2022 segment
Segment Reporting [Abstract]
Number of operating segments	3

XML

Segment and Other Supplemental Information - Regional Segment Revenue and Gross Margin for Company (Detail) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Segment Reporting Information
Segment revenue	$ 496	$ 491
Gross profit	301	307
Selling, general and administrative expenses	157	149
Research and development expenses	76	77
Income from operations	68	81
Americas
Segment Reporting Information
Segment revenue	290	263
EMEA
Segment Reporting Information
Segment revenue	129	147
APJ
Segment Reporting Information
Segment revenue	77	81
Operating segments
Segment Reporting Information
Gross profit	312	315
Operating segments | Americas
Segment Reporting Information
Gross profit	189	182
Operating segments | EMEA
Segment Reporting Information
Gross profit	78	88
Operating segments | APJ
Segment Reporting Information
Gross profit	45	45
Segment reconciling items
Segment Reporting Information
Stock-based compensation costs	5	3
Acquisition, integration, reorganization and transformation-related costs	$ 6	$ 5

XML

Label	Element	Value
Restricted Cash and Cash Equivalents	us-gaap_RestrictedCashAndCashEquivalents	$ 3,000,000